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ABSTRACT 
Stability and specificity of transmembrane domain self-association by 
mutagenesis and protein design 
By 
Todd Michael Jaszewski 
In this thesis, I investigate the sequence dependence of homodimerization 
of the transmembrane domain of the pro-apoptotic C. elegans protein BNIP3. 
Using site directed mutagenesis and two assays for dimerization, I show that the 
tight association of the CeBNIP3 transmembrane domain relies on overlapping 
but distinct sets of residues depending on the assay: in membranes, the critical 
residues are N183xxSFxxxGxxxG194, whereas in detergents, the key residues are 
S186FxxGxxxGxxxS198. The small residue Ser 186, the bulky residue Phe 187, 
and small residues Gly 190 and Gly 194 play key roles in CeBNIP3 dimerization 
in both assays. However, CeBNIP3 TMD self-association in detergents, but not 
membranes, depends critcally on Ser 198; self-association in lipid bilayers, but 
not detergents, depends on Asn 183. Comparison with the previously identified 
dimerization motif for the human BNIP3 ortholog (SHxxAlxxGlxxG) shows that 
the residues that drive CeBNIP3 dimerization in membranes are chemically 
similar to, but distinct from, those that drive HsBNIP3 association. 
iii 
To explore how interfacial BNIP3 residues determine dimer stability and 
specificity, I generated a combinatorial library from the CeBNIP3 and HsBNIP3 
motifs, (S/T)(H/N)xx(A/S)(l/F)xxG(l/A)xxG, and tested the hybrid sequences for 
dimerization. All combinations of interfacial residues support strong to extremely 
strong dimerization in membranes, suggesting that the two parental sequences 
adopt similar structures. Not all sequences form dimers in detergents, and 
dimerization propensity correlates weakly with sequence hydrophobicity. 
Manipulating the solvent conditions to enhance the hydrophobic effect increases 
dimerization of some sequences but not others. 
The CeBNIP3 and HsBNIP3 transmembrane domains form homodimers 
but not heterodimers in detergents. Hybrid motif sequences show differing 
propensities to form heterodimers with wildtype CeBNIP3 TMD and HsBNIP3 
TMD: some hybrids discriminate, binding only one wildtype sequence, and some 
interact with both. My findings identify the sequence elements responsible for 
stability and specificity of BNIP3-type transmembrane domain dimerization. My 
results also show that the hydrophobicity of membrane spans strongly influences 
their behavior in detergent assays of protein-protein interactions. The 
demonstration that altering the aqueous solvent conditions can improve the 
stability of integral membrane proteins in detergents may be of general 
importance in membrane protein biochemistry. 
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1 Introduction 
1.1 Oligomerization of transmembrane domains and the two-stage model of 
folding 
The most commonly occurring transmembrane domains (TMDs) of 
integral membrane proteins are short stretches of hydrophobic amino acids that 
insert into a cellular lipid bilayer and adopt an a-helical conformation [1-3]. While 
most commonly acting as an anchor to localize the protein to a membrane 
surface, recent studies have implicated transmembrane domains as a driving 
force in other cellular processes including protein folding [4-6], oligomerization [7-
9], signal transduction [10, 11], subcellular localization [8, 12-15], and protein 
complex assembly [16-18]. The broad spectrum of biological processes directed 
by transmembrane domains suggests that much information can be encoded in 
these short amino acid sequences. 
Early research on bacteriorhodopsin, a light-driven proton pump consisting 
of seven transmembrane domains, revealed insights into how interactions 
between TMDs contribute to the folding and function of this protein. 
Bacteriorhodopsin can be cleaved via chymotryptic digestion into two parts 
containing two and five transmembrane domain helices; these fragments can 
recombine spontaneously to form a functional protein after being independently 
reconstituted into lipid bilayers, suggesting that the bacteriorhodopsin structure is 
driven by TMD interactions [6]. Two synthetic peptides corresponding to 
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individual TMDs can also be combined with the large chymotryptic fragment to 
create a functional bacteriorhodopsin pump [4]. These early indications of TMD-
driven protein folding led Popot and Engelman to propose a model of membrane 
protein folding that contains two thermodynamically-identifiable steps (Figure 1.1) 
[5]. In the two-stage model, the first stage consists of the insertion of a largely 
hydrophobic amino acid sequence into a lipid bilayer as an a-helix. This step is 
considered essentially irreversible - once a TMD is inserted into a membrane, it 
remains there in an a-helical conformation because the only two alternative 
states, removal of the TMD from the bilayer or disrupting its secondary structure, 
are energetically unfavorable. The former is unfavorable because removal of a 
hydrophobic a-helix into the aqueous phase is strongly opposed by the 
hydrophobic effect, whereas the latter requires disruption of the hydrogen-
bonded backbone within a hydrophobic environment unfavorable to free polar 
groups. Following insertion, the second stage occurs wherein the TMD then 
adopts a functional fold or laterally associates with other TMDs in its vicinity to 
form protein complexes. Stage two might also provide a basis for TMD-mediated 
signal transduction, as some protein oligomerization events have been 
demonstrated to rely on TMD interactions [11, 12, 19-24]. These TMD-mediated 
complexes may result from increased or decreased expression levels and may 
perform disparate biological functions [25, 26]. 
Although the two-stage model of membrane protein folding provides a 
framework within which membrane protein folding can be considered, it ignores 
potential contributions from extramembranous loops and folds, as well as the 
AG, fold 
/ 
/ /AG'insert 
B AG, 
'assoc 
Figure 1.1 Two-stage model for membrane protein folding 
A. Stage 1 of the two-stage model involves the insertion of a transmembrane 
domain into the lipid bilayer. This stage can be considered irreversible due to 
excessive energy requirements for denaturing an cc-helix or removal into the 
cytoplasm. B. Stage 2 involves lateral interactions between a-helices, influ-
enced by the contributions of protein-protein, protein-lipid, and lipid-lipid interac-
tions. 
(adapted from MacKenzie, KR (2006) Chemical Reviews, Vol. 106 No. 5) 
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contributions of other prosthetic groups, ligands, and peripheral domains. Thus, 
the two-stage model is unlikely to capture all the relevant contributions to the 
folding of a complex polytopic protein like bacteriorhodopsin. However, the 
interactions between the TMDs of single-pass membrane proteins may well 
described by the second stage of the two-stage model. The relative simplicity of 
these proteins means that contributions of protein-protein, protein-lipid, and lipid-
lipid contacts will likely suffice to understand the basis for TMD-TMD interactions. 
Of course, such proteins may also interact through their extracellular or 
intracellular domains. In this thesis, I am focusing on identifying the physical 
basis for TMD-TMD interactions, which is currently one of the least understood 
types of protein-protein interactions known to occur in biology. The simplest 
case that can be investigated is homodimerization, as this relies upon the 
contacts of only one self-associating transmembrane domain. 
1.2 A model dimeric transmembrane domain: glycophorin A 
The most abundant sialoglycoprotein in human red blood cells is the 131 
amino acid single-TMD protein glycophorin A (GpA), which has been intensively 
studied as a model transmembrane protein since the 1970s. GpA, which carries 
A/B/O blood type epitopes [27] and parasite binding sites [28], was the first 
integral membrane protein to have its primary sequence determined [29]. The 23 
residue hydrophobic stretch in the second half of the sequence was correctly 
deduced to span the hydrophobic part of the lipid bilayer, and this TMD region 
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was shown to form tight, non-covalent, TMD-mediated homodimers in vitro in 
detergents [11, 30, 31], in model bilayers [32], and membrane-based assays [33, 
34]. Self-association under conditions of SDS-PAGE is disrupted by the 
carboxymethylation of a single methionine 81 residue located in the TMD [30]. 
Synthetic GpA TMD peptides also form homodimers in detergent micelles [35], 
confirming that the TMD is sufficient to support this interaction. As a result of its 
early identification and preliminary biochemical and biophysical characterizations, 
GpA has provided an important model for investigating TMD interactions and 
advancing our understanding of TMD-mediated protein-protein interactions. 
Integral membrane proteins are difficult to express and purify in large 
quantities due to their overall hydrophobicity. To overcome this problem, a 
method was devised wherein the TMD of GpA was fused to the C-terminal end of 
Staphylococcal nuclease (SNase) [11], an easily-expressed and purified soluble 
protein. The resulting fusion construct is homodimeric under conditions of SDS-
PAGE [11], indicating that the construct forms dimers mediated by the attached 
TMD, much like wild-type GpA. Put under the control of a T7 promoter in a 
bacterial plasmid, the construct is an ideal system for mutational analysis of TMD 
dimerization. 
Analysis of GpA TMD dimerization via saturation mutagenesis was 
performed by Lemmon and colleagues, who generated and characterized over 
200 GpA TMD single-residue substitutions [36]. Mutant proteins were 
expressed, purified, and analyzed by SDS-PAGE for their ability to form 
homodimers; phenotypes were ranked in accordance to the ratio of 
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dimer:monomer as evidenced by western blotting results [36]. Based upon 
previous observations that the carboxymethylation of Met81 disrupted 
dimerization in SDS [30], Lemmon et al began saturation mutagenesis at this 
position. They discovered that only mutations to highly polar residues disrupt 
self-association [36] suggesting that Met81 was not involved in 
homodimerization. Reasoning that Met81 may be situated on an incorrect helical 
face, Lemmon et al performed the same mutagenesis experiments on Val84 and 
discovered that, in contrast to their mutations at Met81, even changes to other 
hydrophobic residues abrogated self-association [36]. Dimer:monomer ratios 
varied depending on the size of the substituting residue [36], revealing that close 
packing interactions were contributing to the helix-helix interaction and that Val84 
was involved in these interactions. Every substitution at Gly83, including Ala, 
completely abolishes dimerization on SDS-PAGE, indicating that the interaction 
between TM helices is particularly close at that position [36]. Saturation 
mutagenesis across the 23 residue TMD revealed an interface motif 
(L75lxxGVxxGVxxT87) that is responsible for the homodimeric properties of the 
GpA TMD and which can be introduced into other a-helical TMDs to promote 
specific self-association in detergent [37]. Interestingly, all positions within the 
GpA TMD were sensitive to mutations affecting the hydrophobicity of the protein 
[36]. With few exceptions, replacing residues within the hydrophobic TMD with 
even slightly polar residues such as threonine and serine resulted in mild to 
extreme abrogation of the dimeric properties [36]. This is probably a result of 
interaction with the detergent environment: substitutions to polar sidechains may 
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result in the breaking of the helix to expose polar sidechains to the headgroups of 
the encompassing lipids. 
The seven residue dimerization interface identified by saturation 
mutagenesis of the GpA TMD [36] has played an important role in our 
understanding of transmembrane helix-helix interactions. Subsequent 
biochemical and biophysical experiments have overwhelmingly confirmed the 
importance of these residues to GpA self-association and have produced 
advances in the methods used to examine TMD interactions. The original GpA 
mutagenesis data [36] were used to distinguish between different computational 
models for the GpA interaction surface [38], and the final model closely 
resembles the NMR structure of the GpA TMD dimer [39]. The NMR structure 
confirms that the residues predicted on the basis of mutagenesis data do in fact 
lie at the dimer interface, and the structure was used to explain the molecular 
basis for abrogation of dimerization due to steric clashes caused by substitutions 
at the GpA interface as well as to predict the effects of specific mutations on the 
stability of a GpA dimer [39]. Data from mutagenesis experiments can be 
directly incorporated into computational protocols for predicting the structures of 
TMD oligomers [40]. 
The mutational analyses that identified the glycophorin A interaction 
surface revealed the existence of the GxxxG dimerization motif [36, 41], now 
recognized as a canonical association motif for transmembrane domains [42]. 
The importance of the GxxxG motif and the role of flanking hydrophobic residues 
has been confirmed by sedimentation equilibrium analytical ultracentrifugation 
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studies of the free energy changes in glycophorin A dimerization in detergents 
caused by specific mutations [43-45]. These studies show that, in most cases, 
the effects of mutations on the thermodynamics of self-association can be semi-
quantitatively predicted by steric models using the NMR structure. Hydrophobic 
point mutations affect the energetics of GpA dimerization in the TOXCAT assay 
in much the same way as in detergents [46], further supporting the idea that 
detergent- and membrane-based assays and mutational studies both provide 
data that report on the nature of the helix-helix interface. Saturation mutagenesis 
data can provide key structural information for molecular modeling and is an 
important tool for complete understanding of transmembrane domain 
oligomerization. 
1.3 Biologically Relevant Transmembrane Domain Oligomers 
Interactions between transmembrane domains have been implicated in 
the biological functions of many single-spanning integral membrane proteins. 
Transmembrane domain oligomerization has been shown to be critical to the 
functions of many proteins including ErbB receptor tryrosine kinases, 
erythropoeitin receptor, integrins, SNARE proteins, and many others. These 
proteins rely on TMD-mediated interactions for their structure and function. 
Though many proteins continue to be identified in this expanding field, a handful 
have been investigated in depth and shown to use their TMDs to interact with 
other proteins to perform a critical biological function. 
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The signaling function of the ErbB family of receptor tyrosine kinases has 
been shown to rely upon single-spanning transmembrane domain interactions. 
Altering the interaction between ErbB2 TMDs by mutation of valine644 to 
glutamic acid has been demonstrated to cause constitutive activation of this 
receptor [47]. This phenotypic change occurs despite proper association with the 
cell membrane [48], suggesting the mutation affects a lateral association with 
another element within the lipid bilayer. A biological homodimerization assay 
(TOXCAT, described in detail in section 1.4) demonstrates that the ErbB2 TMD 
dimerizes significantly in the absence of extracellular or intracellular domains [19] 
Site-directed mutagenesis shows that mutations in the GxxxG-like motifs in the 
ErbB2 TMD reduce homodimerization in TOXCAT. This is contrary to mutations 
in a TxxxG motif found in the TMD of ErbB3 that fail to significantly alter its ability 
to homodimerize in a membrane [19]. Analysis of the ErbB-family TMDs reveals 
that the spatial distribution of GxxxG-like motifs influences protein-protein 
interactions in a membrane - those with a motif near the N-terminal end of a 
TMD will behave differently and interact with different proteins than will those with 
the motif located C-terminally [49]. This result is substantiated by the 
introduction of synthetic ErbB1 and ErbB2 TMDs that results in a dominant-
negative effect on signaling by ErbB proteins [50] and by chimeric proteins 
wherein the insulin receptor is fused to the membrane-spanning region of the 
corresponding ErbB proteins [7]. 
Another example of biologically relevant TMD interactions is the 
erythropoietin receptor, which functions to regulate proliferation and 
10 
differentiation of red blood cells in response to erythropoietin. The erythropoietin 
receptor has been shown to dimerize in the cell membrane in the absence of 
ligand [51]. Analysis in the ToxR system has confirmed the ability of the TMD to 
drive self-association [52] while mutational studies have mapped the interaction 
motif to one face of the helix [53]. Mutations created to abrogate TMD self-
association have been shown to disrupt receptor signaling [54]. Additionally, 
interaction of the transmembrane gp55 protein from spleen focus forming virus 
with the erythropoietin receptor TMD appears to activate the receptor [55]. 
1.4 Mapping dimerization motifs in a cell membrane: the TOXCAT assay 
The most extensive mutational analyses of TMD interactions have been 
performed using SNase fusion proteins and SDS-PAGE dimerization assays [11, 
56, 57] Although the SNase-TMD fusion construct is an invaluable tool for rapid 
cloning and screening of TMDs, examining TMD interactions in detergent 
environments is not ideal in terms of biological relevance. The environment 
provided by a detergent micelle can be adjusted to resemble conditions within a 
cell membrane, but it fails to provide constraints that may be present the lipid 
bilayer, including lateral pressures and the inability to break a helix for the 
purpose of unburying a polar sidechain [33]. Biological assays have been 
created to compensate for the shortcomings of detergent assays by measuring 
association of the TMDs of interest within bacterial membranes, including the 
ToxR system [34], TOXCAT [33], and GALLEX [58]. 
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The TOXCAT system is a modification of the ToxR system created by 
Langosch and colleagues [34]. TOXCAT relies upon a three-domain protein 
fusion construct combining (from N- to C-terminus): ToxR (a transcriptional 
activator from Vibrio cholera [59-61]), the TMD to be investigated, and maltose 
binding protein (MBP) [33] (see Figure 1.4.1). The maltose binding protein 
domain is exported to the periplasm, facilitating insertion of the TMD into the lipid 
bilayer and orienting the topology so that the ToxR domain is exposed to the 
cytoplasm [33]. In the event that the TMD protein of the fusion causes self-
association, ToxR domains are brought into close proximity, enabling them to 
bind specifically to the ctx promoter and promote transcription of the reporter 
gene chloramphenicol acetyl-transferase (CAT) [33]. Tight oligomerization of the 
TMD will result in a greater ratio of dimeric:monomeric ToxR and increased 
expression of CAT, whereas weak TMD-mediated oligomerization will yield little 
reporter gene expression. In this way, CAT production is directly proportional to 
the strength of homodimerization of the TMD. CAT production levels have been 
measured indirectly using a zone of inhibition (ZOI) technique, or directly, using 
thin-layer chromatography based CAT activity assays [33]. Recently, I have 
used a colorimetric CAT activity assay [62] to determine CAT expression from 
cleared cell lysates [9]. Several control protocols are available to monitor the 
state of the TOXCAT fusion protein upon which the system, and therefore the 
validity of the data depends. The assays are performed using a malE cell line so 
that the ability of the fusion protein to confer growth on maltose as a carbon 
source can be used to confirm proper orientation of protein insertion 
Figure 1.4.1 TOXCAT - A membrane-based assay for self-associating transmem 
brane domains 
A transmembrane domain of interest is fused between maltose binding protein (large 
circle) and ToxR transcriptional activator (square). Maltose binding protein facilitates 
membrane insertion, while the interaction of the transmembrane domains causes the 
association of the dimeric ToxR, permitting it to bind the ctx promoter and drive tran-
scription of the reporter gene, chloramphenicol acetyl-transferase. 
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into the membrane [33]. Overall construct expression levels are analyzed by 
western blotting for MBP [33], and protein insertion can be monitored physically 
by creation of spheroplasts, proteolysis of exposed epitopes, and western 
blotting [33]. 
Utilizing this new assay, Russ and Engelman were able to demonstrate 
that the helical interactions of GpA observed in SDS were similar to those 
occurring in a lipid bilayer [33]. One notable exception emerged: substitutions 
away from the dimer interface to more polar residues did not result in abrogation 
of oligomerization [33], confirming the idea that disruption by polar substitutions 
in SDS is more likely to be an artifact of unfavorable protein-lipid interactions in a 
micelle environment rather than direct disruption of protein-protein interactions. 
The basic dimerization motif identified in SDS (L75lxxGVxxGVxxT87) was 
maintained in TOXCAT, demonstrating that, despite their limitations, detergents 
can provide useful information about TMD-TMD interactions. Langosch 
examined the glycophorin A transmembrane domain in a membrane-based 
assay using the dimeric transcriptional activator ToxR. Mutational analysis of the 
GpA TMD in a membrane revealed that, while three of the identified interfacial 
residues were essential to dimerization in a bilayer and demonstrated a similar 
phenotype to those observed in SDS-PAGE, substitutions to the other four had 
less dramatic effects, suggesting that the dimer may adopt a slightly different 
structure in a membrane when compared to a micelle or that local concentration 
within the membrane plays a role in the strength of association [34]. 
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The amino acids of the glycophorin A TMD that participate in protein-
protein interactions lie on one face of a canonical a-helix. The spacing of 
interacting residues for other potential dimerization motifs are probably also 
determined by the standard geometry of a-helical TMDs, although the angle at 
which the helices cross can alter how many residues are capable of contacting 
the opposite monomer. Though GpA has long been a standard-bearer of 
membrane protein science, its motif cannot be assumed to be universal to self-
associating integral membrane proteins. The identification of other motifs is 
essential to a full understanding of interacting TMDs. Russ and Engelman 
devised a method in which they utilized the motif residue spacing revealed by 
their GpA studies to create a library of possible dimerization motifs [63]. 
Assuming the spacing of the motif residues to be fixed at the glycophorin A 
spacing, Russ and Engelman allowed the residues at the motif positions to vary 
(any of alanine, glycine, valine, arginine, serine, threonine, isoleucine, leucine, 
and proline) in the context of either a poly-leucine or poly-alanine host sequence. 
The synthesized these libraries with degenerate oligonucleotides encoding up to 
107 unique TMDs sequences [63]. These were ligated into the TOXCAT vector 
and grown against a selective pressure of increasing chloramphenicol (CAM) 
concentrations, yielding a logarithmic decrease in the number of surviving 
colonies as CAM concentrations increased [63]. Plasmids harvested from 
surviving colonies at the highest CAM concentrations revealed a dimerization 
motif consisting of two glycines separated by three unselected amino acids (the 
GxxxG motif) that was represented in over 80% of the strongest associating 
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TMDs (see Figure 1.4.2) [63]. The poly-alanine host sequences demonstrated a 
preference for large non-polar residues immediately preceding the motif glycines, 
while the poly-leucine host sequences demonstrated a similar preference for 
large hydrophobic residues immediately following the motif glycines [63]. While 
providing evidence for the existence of identifiable TMD-TMD interaction motifs, 
these data also suggest that non-motif residues (those excluded from both the 
GxxxG and immediately-adjacent residues) may play some role in the geometry 
of TMD oligomerization. 
When transmembrane domain sequences were analyzed for frequently 
occurring residues, patterns emerged with certain residues being over- or under-
represented [64]. It was found that the small residue glycine (and also alanine or 
serine) were heavily over-represented at positions 7 and i+4, and the larger 
residues leucine, isoleucine, and valine were frequently situated adjacent to 
these positions [64]. Statistical analysis of these observations showed that the 
GxxxG motif occurred over 30% more frequently than expected, a result with an 
astronomically low probability of less than 1*1 fj"33 [64], suggesting that the 
GxxxG motif is positively selected in biological transmembrane domains to 
perform specific and necessary functions. 
1.5 The Bcl-2 superfamily of pro- and anti-apoptotic mitochondrial proteins 
Apoptosis, or directed cell death, is an essential process in complex 
organisms serving to eliminate unneeded, damaged, or misplaced cells during 
LVLLGVLLGVLLTL LGAAVGAAVGAAVA 
LVLLGVLLGLLLAL ISAAVGAALGAAVA 
LILLGALLGGLLTL LGAAIGAAVGAALA 
PGLLGLLLGALLGL IGAAVGAAIGAAAA 
Figure 1.4.2 Examples of strongly-associating transmembrane domains as 
determined by TOXCAT 
Russ and Engelman created a library of randomized transmembrane domain 
interfaces in a poly-leucine or poly-alanine background and analyzed them for 
strong self-association in TOXCAT. The majority of isolated sequences demon-
strating strong dimerization include a GxxxG motif. Those in a poly-leucine 
background show a tendency to possess glycines at positions 5 and 9 that are 
typically followed by large hydrophobic residues. In contrast.tightly-associating 
poly-alanine sequences tend to contain glycines at positions 6 and 10 that tend 
to be preceded by large hydrophobic residues. Only 1 of 49 poly-leucine 
sequences contained a glycine at position 6 without also containing the 5-9 
GxxxG motif. Similarly, only 3 of 72 poly-alanine sequences demonstrate a 
GxxxG motif with a 5-9 positioning. 
Figure adapted from MacKenzie, Chem. Rev, 2006 
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development, healing, and tissue homeostasis [65, 66]. Apoptosis is controlled 
by many complex pathways that respond to varying stimuli, and failure to 
properly direct apoptosis can lead to numerous disorders including cancer [67] 
and autophagy [68]. Apoptotic machinery that has been largely conserved 
throughout evolution [69] includes a set of aspartate-specific cysteine proteases 
known as caspases, which persist at low levels in healthy cells and require 
activation to trigger apoptotic functions [70]. One pathway for activating 
caspase-induced apoptosis includes members of the Bcl-2 family of proteins and 
relies upon pro-apoptotic mitochondrial proteins whose activity or expression is 
primarily initiated by death receptor-independent stimuli [65]. These stimuli can 
begin a process during which the mitochondrial outer membrane becomes 
selectively perforated [71], releasing interstitial proteins such as cytochrome cto 
participate in apoptosis signaling [72, 73]. Participating in these signal pathways 
at the mitochondria are members of the Bcl-2 protein superfamily, a diverse and 
largely membrane-bound family of pro- and anti-apoptotic mediators [74, 75]. 
The genomes of higher-order eukaryotes contain up to 30 distinct 
members of the Bcl-2 family [74, 76], each of which contains from one to four 
Bcl-2 homology domains (termed BH1-BH4) [77-82], and most of which have a 
transmembrane domain at their C-terminal end (see Figure 1.5) [65]. Solution 
structures of Bcl-xL and Bcl-2 show that the BH1-3 domains create a 
hydrophobic groove suitable for binding of ligands [83-85]. Site-directed 
mutagenesis studies have shown that the anti-apoptotic activity of Bcl-2-like 
Pro-survival: Bcl-2 subfamily 
Bcl-2 
Bcl-x^ 
CED-9 
E1B-19K 
[BH31 |BH1| rm^ 
Pro-apoptosis: Bax subfamily 
Bax 
Bak 
Bok 
Pro-apoptosis: BH3-only subfamily 
BH3i i B H i r r a i 
Bik 
Hrk 
BNIP3 
Bid 
Figure 1.5 Selections from the Bcl-2 superfamily of apoptotic mitochondrial 
proteins 
The Bcl-2 family consists of up to 30 pro- and anti-apoptotic proteins, primarily 
localized to the outer mitochondrial membrane. All contain at least one bcl-2 
homology domain (BH- domain) and most possess a c-terminal transmembrane 
domain. BNIP3 and its orthologues belong to the BH3-only subfamily, a collection 
of pro-apoptotic proteins containing only one Bcl-2 homology domain. 
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proteins can be reduced or eliminated by mutations within the BH domains [78, 
82]. 
The most prominent Bcl-2 homology domain is BH3 [65], and a pro-
apoptotic sub-family known as 'BH3-only' proteins can be identified by their lack 
of any other Bcl-2 homology domain [65]. Structural and mutagenesis studies 
have suggested the BH3 domain, though acting as a random coil in normal 
soluble conditions, adopts an oc-helical conformation when binding other Bcl-2 
homology domains [78, 82-84, 86]. The BH3 domain is not constitutively 
exposed, however, and may rely on modification or conformational change for 
activation [87]. Despite much evidence supporting cytosolic interactions between 
members of the Bcl-2 protein superfamily, these contacts do not necessarily rely 
only upon Bcl-2 homology groups. Some proteins identified by yeast two-hybrid 
studies as Bcl-2 binding partners do not possess Bcl-2 homology domains [88], 
indicating that other structural or sequence motifs may support protein-protein 
interactions in these systems. The transmembrane domains of some Bcl-2 
superfamily proteins have been shown to mediate specific protein-protein 
interactions both in vitro [8, 9, 57, 89-91] and in membranes [8, 9, 89-91], 
indicating another potential mode of protein interaction. 
BH3-only proteins identified to date are death factors that show homology 
with one another only through the BH3 domain each contains [75, 76]. The 
C.elegans pro-apoptotic BH3-only protein EGL-1 [92, 93] interacts via its BH3 
domain with CED-9, resulting in the release of CED-4 and permitting the 
autoprocessing of CED-3 and subsequent caspase activity [94, 95]. 
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Interestingly, EGL-1 loss-of-function mutants demonstrate only a reduction in 
caspase activity [96]. Persistence of caspase-mediated apoptosis suggests 
other BH3-only proteins could exist in C. elegans. Currently, more than 10 BH3-
only proteins have been identified [65] in mammals, including Nix [97], Hrk [98], 
and Bid [99]. 
1.6 Bcl-2/adenovirus E1B 19-kDa protein-Interacting Protein 3 
The regulation of one BH3-only protein has been the focus of medical 
study particularly in the areas of cardiomyopathy and oncology: BNIP3 (Bcl-
2/adenovirus E1B 19-kDa protein-interacting Protein 3), a 194 amino acid protein 
first identified by its interaction in yeast two-hybrid assays with Adenovirus E1B 
19kD protein [100]. Research into BNIP3 function identified it as a dimeric pro-
apoptotic mitochondrial protein that increased cellular sensitivity to granzyme B 
and topoisomerase-induced apoptosis [101]. The C-terminal end of the protein 
(residues 164-194), containing the transmembrane domain, is critical to both 
dimerization in detergent and localization of the protein to the mitochondria [101, 
102]. Cells overexpressing anti-apoptotic Bcl-2 are resistant to the effects of 
BNIP3 for a limited time, after which BNIP3 is able to overcome this protective 
effect [101]. Additionally, it was found that expression of a ATMD mutant did not 
induce apoptosis, suggesting that (at the very least) localization to the 
mitochondrial membrane is critical for BNIP3 function [101]. While the BH3 
domain is required for heteromeric interactions between many Bcl-2-family 
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members [84, 87, 91], evidence suggests that the BH3 domain of BNIP3 is not 
essential for oligomerization or its pro-apoptotic activity [101]. BNIP3 is 
conserved across eukaryotic species from C. elegans to humans [103], and 
though BNIP3 sequences diverge across such distances, all contain a BH3 
domain and a C-terminal transmembrane domain. 
Studies show that BNIP3 expression is regulated by hypoxia-inducible 
factor 1a (HIF-1a) [104-106] and expressed in response to such stimuli as 
hypoxia [104,107] and acidosis [105, 107] but repressed in response to nitric 
oxide [108]. The BNIP3 promoter contains a binding site for HIF-1a and the 
increase of BNIP3 expression levels in response to hypoxia [104] has long been 
a subject of cardiomyocyte research because of the role of BNIP3-induced 
apoptosis following cardiac ischemia in the death of heart tissue [105, 107, 109]. 
More recently, alterations to BNIP3 expression and reduced apoptosis have been 
linked to DNA modifications in several forms of cancer [110-117] including 
methylation of a GC-rich island upstream of the BNIP3 promoter, particularly in 
pancreatic cancers [114-116]. Reduction of BNIP3 expression in tumors can be 
used as a tumor progression marker to evaluate or predict patient survivability 
[118]. These results imply that one biological role of normal BNIP3 function is 
tumor-suppression. 
The exact role of BNIP3 in the promotion of apoptosis is not well 
understood. Overexpression of BNIP3 causes association with, and opening of, 
mitochondrial permeability transition pores (PTPs) that reduce and eliminate the 
electrochemical gradient between the mitochondrion and cytosol, eventually 
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leading to DNA fragmentation [119, 120], though the actual cell death caused by 
BNIP3 resembles necrosis more than apoptosis [120]. In contrast to caspase-
dependent apoptosis promoted by other Bcl-2 family members, BNIP3 
overexpression does not induce cytochrome c release, nor do caspase inhibitors 
affect BNIP3-mediated apoptosis [120], suggesting it to be caspase-independent. 
Furthermore, while some studies suggest that BNIP3 function relies upon the 
BH3 domain [102], others show that apoptotic function is unaffected by the 
removal of this domain [8, 120]. One consistent result, however, is that the 
presence of the C-terminal end containing the transmembrane domain is crucial 
to proper BNIP3 localization and function [8,102] and that this TMD is essential 
to dimerization in detergent and yeast two-hybrid assays [101]. The TMD alone 
is also sufficient to drive homodimerization both in detergent micelles and in a 
cellular membrane [9]. 
All identified BNIP3 TMDs contains a GxxxG motif near the C-terminal end 
- in higher order species, this motif resides at the C-terminus of the TMD. All 
BNIP3 proteins also contain a pair of polar amino acids near the middle of the 
transmembrane sequence, either as a pairing of serine and histidine (residues 
172 and 173, respectively, in the human sequence) or of threonine and 
asparagines (residues 182 and 183 in C. elegans). Solution NMR structures and 
mutagenesis studies have indicated that the serine-histidine pairing in human 
BNIP3 forms an interhelical hydrogen bond between dimerizing TMDs, 
increasing their stability [57, 121]. When analyzing these polar residues by 
species, the serine-histidine pairing is represented almost entirely by vertebrate 
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species, whereas invertebrate species (with the exception of Nematostella 
vectensis) contain the threonine-asparagine pairing. Interestingly, only one 
known sequence has a mixture of these two pairs - Nix, a BNIP3 ortholog (a 
close homolog of BNIP3), exhibits a threonine-histidine pairing in Danio rerio. A 
small residue is also conserved between the polar amino acid pair and the 
GxxxG motif and is consistently located on the same helical face as the other 
conserved residues. Alanine is present in higher order eukaryotes and serine in 
lower order, though alanine appears earlier in the evolutionary web than the 
previously-discussed polar residues. This conservation within the BNIP3 
transmembrane domain may indicate the preservation of an evolutionarily 
conserved biological function, despite a lack of conservation in the flanking 
residues of the TMDs. A more complete discussion of the conservation of BNIP3 
TMD sequences, together with a sequence alignment, is presented in Section 
2.5. 
1.7 CeBNIP3 is a conserved BNIP3 ortholog containing a self-associating 
transmembrane domain 
Caenorhabditis elegans is a nematode used as a model organism, and the 
production of a detailed map of cell lineages in this small and transparent worm 
[122-126] led eventually to the discovery of apoptosis as a genetically regulated 
process. C. elegans contains a select grouping of Bcl-2- and caspase-like 
proteins that direct programmed cell death in a manner similar to that observed in 
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mammalian cells. CED-9, a homolog of mammalian Bcl-2 [127], suppresses cell 
death by interacting with CED-4 [128]. CED-4 is activated by Egl-1 binding to 
CED-9, which compromises the CED-4:CED-9 oligomer, freeing CED-4 to 
interact with CED-3 [92, 129]. CED-4 facilitates processing of CED-3, a 
caspase-like protein [130] which then drives the apoptotic pathway [131-133]. 
CeBNIP3 was first identified as a BNIP3 ortholog in 1998 via a BLASTP 
algorithm used to search the C. elegans genome [103]. The algorithm 
discovered an area of high homology between human BNIP3 and gene C14F5.1 
of C. elegans [103]. CeBNIP3 shares 21% identity and 42% similarity with 
BNIP3 over the entire amino acid sequence [12]. Like its orthologs BNIP3 and 
NIX, CeBNIP3 contains a hydrophobic transmembrane domain, a putative BH3 
domain, and a PEST sequence [12]. Further comparison revealed a similarity 
between the CeBNIP3 transmembrane domain and those commonly found in 
Bcl-2 proteins [103] and the observation that CeBNIP3 immunoprecipitates with 
CED-9 [103] is analogous to the interaction of BNIP3 with Bcl-2 [127]. This 
transmembrane domain is necessary for both dimerization in vitro and for 
CeBNIP3 pro-apoptotic function when overexpressed in mammalian cells [12]. 
CeBNIP3 can induce apoptosis when transfected into human 293 cells, 
indicating that it can maintain its pro-apoptotic function in mammalian cell death 
pathways and is, in fact, nearly as proficient as its human ortholog at inducing 
cell death [103]. CeBNIP3 interacts with CED-3 and a catalytically-inactive CED-
3 mutant via its cytoplasmic domain and expression of both CeBNIP3 and CED-3 
in human cells can induce significant levels of apoptosis [103], similar to results 
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seen by transfection of CED-3 and CED-4. Interestingly, co-expression in cells 
transfected with CeBNIP3, CED-3, and CED-9 resulted in low apoptotic levels, 
suggesting that CED-9 expression diminishes the pro-apoptotic effect of 
CeBNIP3 [103] - indeed, a ternary complex consisting of these three proteins 
can be immunoprecipitated [103]. The pro-apoptotic functions of CeBNIP3 are 
maintained in mammalian cells, and CeBNIP3 interacts with many of the same 
mammalian interaction partners as BNIP3. CeBNIP3-induced apoptosis can be 
suppressed by expression of BCI-XL, much as BCI-XL expression blocks the pro-
apoptotic activity of mammalian BNIP3 [12]. Yeast two-hybrid assays reveal a 
propensity of CeBNIP3 to form oligomers with BNIP3, Bcl-xL, and CED-9 in vivo 
[12], and immunoprecipitation studies demonstrate that the interactions with 
CED-9 and BCI-XL rely upon the transmembrane domain for their interactions [12]. 
The precise mechanism of CeBNIP3-mediated cell death remains poorly 
understood. Like human BNIP3 [120], CeBNIP3-induced apoptosis does not 
respond to caspase inhibitors [12], denoting a capase-independent mechanism. 
Additionally, CeBNIP3 appears to be rapidly degraded by the proteasome after 
approximately 24 hours of expression and following ubiquitination [12]. Removal 
of either the BH3 domain or the conserved domain of CeBNIP3 fails to reduce its 
apoptotic effects, whereas deletion of the transmembrane domain almost 
completely destroys the ability of CeBNIP3 to drive apoptosis [12]. CeBNIP3 
expression, alone, appears unable to initiate apoptosis and, while providing a 
small increase to the killing mechanism of an expressed CED-3:CED-4 complex, 
this additive effect is minimal [12]. 
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1.8 Investigation of CeBNIP3 specificity in detergents and biological 
membranes 
In the remaining pages of this manuscript, I will describe in detail the 
experiments performed to examine the specificity of the CeBNIP3 
transmembrane domain dimerization in SDS detergent and in biological 
membranes. I will discuss the single-residue substitutions I created in the 
CeBNIP3 TMD to determine which residues contribute to CeBNIP3 self-
association. 
In chapter 2 of this thesis, I investigate the conservation of BNIP3 TMDs 
across species and demonstrate that human, D. melanogaster, and C. elegans 
BNIP3 TMDs dimerize tightly in biological membranes and that CeBNIP3 TMD 
can drive dimerization under conditions of SDS-PAGE. Additionally, I investigate 
the extent to which the TOXCAT assay can be manipulated to increase its 
sensitivity to disruptive mutations in self-associating transmembrane domains. In 
chapter 3 of this thesis, I investigate the contributions of each residue in the 
C. elegans BNIP3 TMD to self-association using both the SDS-PAGE assay and 
the TOXCAT system. I describe how the GxxxG motif, identified as a critical 
component of many oligomerizing TMDs (see section 1.4), forms the crux of 
interacting CeBNIP3 TMD monomers. I describe how, using in vitro and 
membrane-based assays, I identify dimerization interfaces for CeBNIP3 TMD in 
detergent and in TOXCAT, and how these interfaces have common elements but 
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are not identical. In chapter four, I mix elements from the HsBNIP3 TMD 
interface with those from the CeBNIP3 TMD interface to determine which 
combinations of similar residues support dimerization. I demonstrate that in a 
biological membrane, hybrid BNIP3 proteins likely form a common structure 
capable of strong homodimerization. I also show that most of the hybrid BNIP3 
motifs are incapable of self-association in the context of SDS-PAGE. Finally, I 
show that overall TMD hydrophobicity is an important determinant of hybrid 
BNIP3 protein dimerization in SDS-PAGE, but not in membranes. 
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2 Measuring BNIP3 Ortholog Transmembrane Domain Self-association 
In this chapter, I describe methods for measuring the self-association of 
transmembrane domains and their application in characterizing the TMDs of 
BNIP3 orthologs. First, I will describe the TOXCAT and SDS-PAGE methods as 
I have implemented them. After establishing the validity of these methods, I 
describe my findings with the human, D. melanogaster, and C. elegans BNIP3 
TMDs. Based on these results, I justify extensive mutagenesis studies of the 
human BNIP3 transmembrane domain and a rationale for investigating the C. 
elegans ortholog using the same methods. 
2.1 Measuring transmembrane domain oligomerization with TOXCAT 
To rapidly screen transmembrane domains for self-association, I used the 
TOXCAT assay as described by Russ and Engelman [33]. DNA sequences 
encoding targeted TMDs were created by PCR amplification and ligated in-frame 
into the pccKAN(AKAN) TOXCAT plasmid to produce a ToxR'-TMD-MBP fusion 
construct. The pccKAN(AKAN) plasmid also contains a constitutively expressed 
ampicillin resistance gene, permitting selection based on antibiotic resistance. 
These plasmids were then transformed into NT326 (malE) cells and grown in the 
presence of 50 jxg/mL ampicillin or carbenicillin to an OD420 between 0.2-0.4, at 
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which time aliquots were taken, brought to 15% glycerol, and stored at -80C until 
needed. 
I determined the relative levels of dimerization of different TOXCAT 
constructs by comparison to the positive control glycophorin A (GpA, a strongly 
homodimerizing TMD) and the negative control GpA-(G83l) (a disruptive mutant) 
using two experimental approaches. Approximate chloramphenicol acetyl 
transferase (CAT) reporter gene expression levels were inferred from a zone of 
inhibition (ZOI) assay that measures the ability of £ coli to grow in close 
proximity to a source of chloramphenicol [33]. More accurate and precise 
measures of CAT levels were obtained by enzymatic assays of cleared cell 
lysates [9] 
2.1.1. Confirming proper insertion of TOXCAT fusion proteins into the cell 
membrane using malE complementation 
Controls to determine proper insertion of each fusion construct into the cell 
membrane were performed by plating transformed NT326 (malE) cells onto M9 
media containing 0.4% maltose as the sole carbon source. Proper insertion of a 
TOXCAT construct into the membrane will localize the maltose binding protein 
domain to the periplasm, which can rescue the inability of £ coli lacking an 
endogenous maltose binding protein to grow on maltose as a carbon source [9, 
19, 33, 34]. Growth of colonies demonstrates proper topology of protein insertion 
into the membrane. 
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Cells were grown to OD420 = 0.8-1.2 at which time 1 ml_ of culture was 
withdrawn and centrifuged. Pelleted cells were resuspended in sterile buffer (20 
mM Tris, 0.5 mM EDTA) to dilute remnants of growth medium and centrifuged 
again. Pelleted cells were resuspended in 100 [iL sterile buffer and streaked 
onto M9 plates containing 0.4% maltose, then incubated at 37C until colonies 
could be identified (typically 72-96 hours). Visible cell growth was recorded as a 
positive result. 
2.1.2. Determination of TOXCAT fusion protein expression levels via western 
blotting 
The relative amount of fusion protein expressed by a given clone was 
examined by western blotting with antibodies targeting the maltose binding 
protein subunit. Sonicated whole cell lysate aliquots were saved from TOXCAT 
sample preparations (see section 2.1.4) and frozen for use in western blotting. 
These aliquots were thawed and mixed with 2* loading dye and separated by 
SDS-PAGE. Protein was then transferred to nitrocellulose membranes and 
blocked with milk. Anti-SNase antibody was applied for one hour at room 
temperature, after which the membrane was washed with TBST (10 mM Tris (pH 
8.0), 150 mM NaCI, 0.1% (v/v) Tween-20). Anti-rabbit antibody conjugated to 
horseradish peroxidase was applied to bind the primary antibody, after which the 
membrane was again washed with TBST. Chemiluminescence detection 
reagents (Amersham) were then applied. Images of the blots were taken either 
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via exposure to chemiluminescent-sensitive film or using an Alphalnnotech 
FluorChem 5500 gel documentation system. 
2.1.3. ZOI measurements for cells carrying the TOXCAT plasmid 
The TOXCAT assay uses the expression of chloramphenicol acetyl-
transferase (CAT) driven by dimeric ToxR' binding to the ctx promoter as the 
reporter of TMD dimerization [33]. Dimerization of TOXCAT fusion constructs 
depends upon the propensity of the included TMD to self-associate; strongly 
associating TMDs result in greater expression of CAT and increased reporter 
gene activity when compared to non-associating transmembrane domains (figure 
2.1.3) [33]. In this way, quantification of CAT expression indirectly provides an 
estimation of the strength of homodimers formed by assayed TMDs. 
Russ and Engelman used a disc diffusion assay to examine the relative 
CAT activity of different constructs. In this assay, chloramphenicol-saturated 
filter discs were applied to lawns of freshly plated cells carrying the TOXCAT 
vector and the amount of CAT expressed in the cells was quantified by the size 
of the zone of inhibition (ZOI) after 12-16 hours of growth [33]. Cells closest to 
the disc experience the highest concentration of chloramphenicol; for cells 
expressing no CAT, the lawn grows only within 12 mm of the disc, whereas cells 
with high levels of CAT can survive within 2 mm of the disc. I initially used a 
slightly modified disc diffusion assay to examine CAT activity driven by CeBNIP3 
TMD clones and controls. Cells were grown to approximately OD420 = 1 0, at 
Figure 2.1.3 Determining chloramphenicol acetyl-transferase activity in 
TOXCAT using a ZOI assay. 
The Zone of Inihibition (ZOI) assay was used by Russ and Engelman in their 
original development of TOXCAT (Russ, 1999). NT326 cells containing the 
desired TOXCAT gene plasmid were grown and diluted to a desired concentra-
tion, then plated onto LB containing 50mg/ml_ ampicillin. A filter disc containing 
60|j.L of 90mg/mL chloramphenicol is placed in the center of the plate, which is 
then incubated overnight at 37C. CAT expression is inferred by the proximity of 
growth to the antibiotic-containing disc. Plates are photographed and the disc 
and ZOI radius measured by ellipse tools using CorelDraw. Reported ZOI is the 
area of the disc subtracted from the area of the ZOI + disc. Left is glycophorin A, 
a strongly-associating transmembrane domain. Center is gylcophorin A (G83I), a 
disruptive mutant. Right is HsBNIP3. 
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which time 0.2 ODs were pelleted by centrifugation. Pelleted cells were 
resuspended in 1.0 ml_ Luria-Bertani (LB) broth. 100 JJL of resuspended samples 
were plated on 100 mm Petri dishes containing 20 ml_ LB medium. Filter discs 
that had been saturated with 60 pL of 90 mg/mL chloramphenicol and dried were 
laid in the center of the Petri dishes. Plates were inverted and incubated 
overnight at 37C. Digital images of the plate were used to determine the ZOI by 
measuring the region clear of bacterial lawn using an ellipse tool in CorelDraw. 
Subtracting the area of the disc from the area of the ZOI + disc yields the area of 
the ZOI in cm2. Smaller ZOIs are indicative of greater CAM resistance and 
therefore stronger self-association. Western blots with antibodies directed 
against MBP (see section 2.1.2) were used to determine the relative expression 
levels between clones; expression levels were roughly similar in all cases. 
Although this assay easily distinguished between the positive and 
negative controls (see Figure 2.1.3), the BNIP3 TMDs associated more strongly 
than the GpA positive control. I suspected that the assay might not be 
sufficiently sensitive to reveal changes in CAT production resulting from 
mutations to BNIP3 TMDs that had modest effects on dimerization, and so I also 
subjected a series of clones to enzyme activity assays. 
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2.1.4 Measuring chloramphenicol acetyl-transferase activity in cells carrying the 
TOXCAT plasmid 
Although thin-layer chromatography based assays for CAT enzyme 
activity have been used with TOXCAT [33], this method gives large standard 
deviations and uses expensive radioactive isotopes or fluorescent tags. The 
Shaw spectrophotometric assay measures CAT activity in a cell lysate by 
exploiting the reactivity of the free thiol in the coenzyme A that is released when 
CAT transfers an acetyl group from acetyl-CoA to chloramphenicol (CAM). The 
liberated CoASH group can react with 5,5'-dithio-b/s-(2-nitrobenzoic) acid 
(DTNB), yielding a CoA-thionitrobenzoic acid disulfide and free 5-thio-2-
nitrobenzoate, which has an extinction coefficient of 13,600 at 412 nm whereas 
the original disulfide is colorless [62] (see Figure 2.1.4.1). For our TOXCAT 
assays, we use a reaction solution with a final concentration of 100 mM Tris (pH 
7.8), 0.2 mM acetyl-CoA, and 1 mM DTNB [62]. 300 ^ L reaction solution is 
mixed with 12 jaL prepared sample and background absorbance is recorded for 
two minutes to obtain the slope of background absorbance due to non-specific 
acetyl-CoA hydrolysis by unrelated enzymes in the cleared cell lysate. 12 [d. 2.5 
mM CAM is added to the sample to start the reaction and absorbance readings 
at 412 nm are taken for one minute to determine the initial slope of absorbance 
increase. The background slope is subtracted from the reaction slope to 
determine the rate of absorption increase and, using the extinction coefficient, 
this value is converted to CAT units of activity (1 unit = the amount required to 
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Figure 2.1.4.1 Measuring CAT levels in TOXCAT by spectrophotometry 
A. The colorimetric Shaw assay detects the chloramphenicol-dependent con-
sumption of Acetyl-CoA by CAT. This frees the CoASH thiol to react with 
5,5'-dithiobis-(2-nitrobenzoic acid) and release 2-nitro-5-mercaptobenzoic acid, 
which absorbs light at the 412nm wavelength. The rate of increase of absorption 
at 412nm is recorded and used to infer CAT activity. B. Graph of CAT production 
by the positive control glycophorin A and the disruptive mutant glycophorin A 
(G83I) as measured using the Shaw spectrophotometric assay. Wild-type GpA 
exhibits CAT production in excess of 20 times the disruptive G83I mutant when 
assayed in TOXCAT. 
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convert 1.0 nanomole of chloramphenicol and acetyl-CoA to 3-acetyl 
chloramphenicol and CoA per min at pH 7.8 at 25 °C [134]). Increased levels of 
CAT activity are an indication of an increased amount of dimeric TOXCAT fusion 
protein. Western blots with antibodies directed against MBP (see section 2.1.2) 
were used to determine the relative expression levels between clones; 
expression levels were roughly similar in all cases. 
For a set of TOXCAT assays on a given day, cultures of the constructs to 
be measured were inoculated from glycerol stocks along with positive and 
negative controls (GpA and the non-dimerizing GpA-G83l mutant); for studies 
involving mutagenesis of a given TMD sequence, the wildtype TMD was also 
inoculated as a control. Cultures were grown overnight to saturation (about 12-
14 hours), and aliquots from each culture were diluted to identical concentrations 
in fresh LB media. Equilibrated cultures were grown to a density of OD42o=1 0-
1.2. Three optical densities were collected and lysed by sonication. Aliquots of 
whole cell lysate were stored for western blotting and the remainder centrifuged 
to remove membrane and cellular debris. Centrifuged cell lysate was then stored 
on ice until used. 
This provides a more accurate assay that is more sensitive to partially-
disruptive mutations in BNIP3 TMDs. When comparing data from the 
spectrophotometric assay to ZOI data (figure 2.1.4.2), I discovered that the size 
of the zone of inhibition does not show a linear relationship to the amount of CAT 
produced, suggesting a diffusion effect of chloramphenicol through agar. This 
accounts for the failure of mutations in BNIP3 TMDs to significantly increase the 
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Figure 2.1.4.2 Zone of Inhibition does not demonstrate a linear dependence 
on CAT expression in TOXCAT 
The Zone of Inhibition (ZOI)-based TOXCAT assay is insensitive to significant 
decreases in CAT production. When plotting units of CAT (as determined by the 
Shaw assay described in section 2.1) against the observed ZOI, an exponential 
relationship emerges, suggesting that chloramphenicol concentrations in agarose 
plates does not diffuse linearly. Thus, mutations resulting in a significant 
decrease in CAT production fail to demonstrate a similarly-increased ZOI. This 
chart uses values ascertained from mutants of HsBNIP3, DmBNIP3, controls, 
and non-associating transmembrane domains analyzed in both ZOI-based and 
Shaw assays. 
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ZOI and indicates that the spectre-photometric assay is more appropriate for 
further TOXCAT studies of BNIP3 TMDs. 
2.2 Screening transmembrane domain oligomerization in vitro using 
Staphylococcal nuclease fusion constructs in SDS-PAGE 
I used the Staphylococcal nuclease (SNase) assay as described by 
Lemmon et al [11] to rapidly screen the ability of a transmembrane domain to 
self-associate in detergent. In addition to revealing the propensity of a TMD to 
homodimerize in detergent, I can also mix these proteins with a TMD peptide (a 
SNase-TMD fusion protein cleaved with a protease to remove the SNase unit) to 
investigate the abilities of specific TMDs to hetero-oligomerize. The ability of the 
SNase fusions to form oligomers in detergents also suggests conditions in which 
stable complexes may be obtained for structural determination by solution-state 
nuclear magnetic resonance (NMR). 
Building and using a SNase fusion to test for transmembrane domain 
oligomerization is relatively straightforward (although, as discussed in detail, 
interpreting the data is not always straightforward). The DNA sequence 
encoding a transmembrane domain of interest is generated by PCR and ligated 
in-frame to the C-terminal end of the SNase protein [11, 56, 57]. Ligated DNA is 
transformed into competent cells (Novablue), spread on plates containing 50 
ng/ml ampicillin, and single colonies are picked and grown for DNA preparation. 
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Figure 2.2 /n w'fro screening for self-associating transmembrane domains 
using a Staphylococcal nuclease (SN) construct 
Transmembrane domains can be fused to SN and screened for association in 
detergents. SN runs as a monomer in SDS-PAGE. The fusion of a self-
associating transmembrane domain drives dimerization of the fusion protein. A 
TMD peptide added to the protein causes the emergence of a heterodimer 
protein/peptide band. 
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Prepared plasmid is sequenced and transformed into the BL-21(DE3) expression 
strain, which provides a copy of the T7 RNA polymerase under control of the lac 
promoter so that SNase fusion protein expression can be driven by inducing 
polymerase expression with IPTG. Colonies are picked and grown in LB medium 
to an approximate OD42o of 0.2, brought to 15% glycerol and frozen at -80C until 
needed. Inoculations are taken and grown to OD42o=0.8 at which time IPTG was 
added to a concentration of 5 jxM. Cells were incubated at 37C with shaking for 
three hours, after which they are pelleted and resuspended in lysis buffer (20 mM 
Tris, 2 mM EDTA). Cells are lysed by multiple freeze/thaw and sonication cycles, 
with the addition of CaCb to a final concentration of 1 mM prior to the final 
freeze/thaw. Cell lysates are pelleted and resuspended in lysis buffer. Aliquots 
are taken and diluted with 2* PSB loading buffer and run in SDS-PAGE. Protein 
is visualized by staining with Coommassie blue or western blotting with 
antibodies targeted against SNase (figure 2.2). 
2.3 Non-associating transmembrane domains demonstrate low TOXCAT 
signals compared to glycophorin A 
The GxxxG motif has been demonstrated to be essential to 
homodimerization in glycophorin A [36, 37, 44, 64, 135,136]. Additionally, the 
GxxxG motif is observed at a greater frequency in TMDs than random chance 
would indicate [64]. The presence of a GxxxG motif (or the related GxxxA motif 
and other variants [37, 63, 137]) in a transmembrane domain can suggest a 
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homodimeric function and would suggest that such biologically active TMDs are 
commonly found. However, previous results have demonstrated that TMD 
dimerization properties observed in membranes do not always match 
observations in detergents. When studying the association of ErbB 
transmembrane domains in TOXCAT, Mendrola et al discovered that the 
transmembrane domains strongly and specifically self-associate, utilizing one or 
more GxxxG motifs to form homodimers in cell membranes [19]. These 
interactions were later investigated in detergents using SDS-PAGE and analytical 
ultracentrifugation by Stanley and Fleming, who found that these TMDs failed to 
interact significantly in micelles [138], indicating that a micelle environment may 
alter the interactions of transmembrane domains when compared to a cell 
membrane. Other analytical ultracentrifugation studies revealed a complex 
relationship between GxxxG motifs and flanking residues at a helical interface: 
while some GpA sequences with disrupted GxxxG motifs retained an ability to 
form homodimers in detergents, other sequences containing an intact GxxxG 
motif might be unable to dimerize [135]. Additionally, mutational studies of the 
syndecan protein family have demonstrated that while all syndecan proteins 
contain a GxxxG motif, syndecan-1 fails to form homodimers either in cell 
membranes or in SDS-PAGE [139]. These data suggest that, though they play a 
significant role in the oligomerization of some transmembrane domains, GxxxG 
motifs and variants are not sufficient for strong TMD homodimerization. 
I performed TOXCAT assays on the TMDs of human insulin receptor 
(INSR), human beta-amyloid precursor protein (p-APP), harakiri (Hrk, a BH3-only 
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Bcl-2 superfamily protein), and B lymphoid kinase (Blk) (figure 2.3). The TMD 
sequences were ligated in-frame into the TOXCAT expression vector and 
transformed into NT326 cells. Cells were grown and samples prepared as 
described in section 2.1. Analysis of CAT activity by TOXCAT using the Shaw 
assay (section 2.1.3) revealed that none demonstrated a significant amount of 
reporter gene activity, strongly indicating an inability to form homodimers in a cell 
membrane. p-APP, which exhibited the strongest dimerization of these four 
proteins, demonstrated CAT activity roughly 20% of the positive control, GpA, 
while Blk and INSR showed no significant ability to homodimerize. These results 
demonstrate that the expression and insertion of TMDs from the TOXCAT vector 
do not constitutively activate the TOXCAT reporter gene pathway. 
2.4 Human BNIP3 TMD homodimerizes strongly in TOXCAT in a sequence-
dependent manner 
The transmembrane domain of human BNIP3 (HsBNIP3) has been 
previously implicated in BNIP3 dimerization when assayed via SDS-PAGE and 
yeast two-hybrid assays [101]. Additionally, research performed in our lab by 
Endah Sulistijo revealed that the HsBNIP3 TMD homodimerizes in a sequence-
specific manner dependant upon an interacting motif (SHxxAlxxGxxlG) when 
analyzed in detergent and that mutations to this interface could abrogate 
dimerization [9, 57]. 
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Figure 2.3 Self-associating transmembrane domains exhibit high reporter 
gene production in TOXCAT 
TOXCAT can be used to demonstrate the capability of a transmembrane domain 
to homodimerize in a cell membrane. Glycophorin A (GpA), a strongly-
homodimerizing transmembrane domain, exhibits strong association in TOXCAT, 
whereas the disruptive Glycophorin A (G83I) mutation abrogates self-association. 
TMDs from BNIP3 proteins universally drive strong dimerization in membranes. 
Non-associating transmembrane domains, such as harakiri (Hrk), beta-amyloid 
precursor protein (PAPP), insulin receptor (INSR), and B lymphoid kinase (Blk) 
demonstrate little or no signal in the TOXCAT assay. In this way, TOXCAT can 
be used as a high-throughput screen for transmembrane domain associations in 
membranes. 
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To investigate the ability of HsBNIP3 TMD to self-associate in a cell 
membrane, I created a TOXCAT expression vector containing the HsBNIP3 TMD 
sequence. NT326 transformants were obtained and TOXCAT samples prepared 
as described in section 2.1. When assayed using the Shaw colorimetric assay 
(section 2.1.3), HsBNIP3 TMD demonstrated levels of reporter gene activity in 
excess of 200% that displayed by glycophorin A, indicating a very strong 
tendency toward homodimerization [9]. To investigate the sequence-
dependence of HsBNIP3 TMD homodimerization using TOXCAT, I recreated 
several mutants previously characterized as disruptive in SDS-PAGE by Endah 
Sulistijo. Mutations to the H173, A176, and G180 positions demonstrated reduced 
TOXCAT signals similar to the effects of the same mutations in detergent (figure 
2.4) [9]. Mutation of the G178 residue, an amino acid not participating in TMD-
TMD association, did not affect dimerization [9]. From these results I conclude 
that the HsBNIP3 TMD relies upon a specific association interface in TOXCAT 
that is identical to that observed in SDS-PAGE. 
2.5 Drosophila melanogaster and Caenorhabditis elegans BNIP3 
transmembrane domains associate tightly in TOXCAT 
Although Bcl-2 family members have been identified in all metazoans, not 
all human Bcl-2-type proteins have direct orthologs in model organisms: for 
instance, C. elegans has fewer than ten Bcl-2 family members [92, 93, 95, 127, 
130,140-142], whereas in humans more than 20 have been identified [143]. The 
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Figure 2.4 Human BNIP3 TMD dimerizes strongly in TOXCAT and deter-
gents in a sequence-specific manner 
The transmembrane domain of HsBNIP3 forms strong homodimers in both deter-
gents and cell membranes. A. The c-terminus and transmembrane domain of 
HsBNIP3. The transmembrane domain is underlined. B. HsBNIP3 (WT) self-
associates strongly in SDS-PAGE. Most mutations to the homodimer interface 
(including residues S172, H173, A176, and G180) strongly disrupt HsBNIP3 
dimerization in detergents, whereas residues similar in size and structure to the 
wild-type amino acid are frequently tolerated. An exception to this is G180, the 
crossing point of the helix-helix homodimer, at which position all mutations disrupt 
completely. Mutations to non-interfacial residues typically fail to disrupt dimeriza-
tion, illustrated by G178I. C. TOXCAT results generally mimic the phenotypes 
observed in SDS-PAGE, though disruption is reduced. These results suggest 
BNIP3 TMD functions similarly in detergent as in membrane. 
Adapted from Sulitijo et al, 2003 
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role of BNIP3 proteins in apoptosis may be moderately well conserved because 
BNIP3 orthologs are found in distantly related organisms, based on sequence 
identity and similarity in the BH3 region, the transmembrane domain, PEST 
sequences, and a 19 residue region restricted to BNIP3 and homologs [12, 103]. 
To date, over a dozen BNIP3 orthologs have been identified and logged in 
PubMed (Figure 2.5.1). All of these proteins share sequence identity and 
similarity within the TMD regions, including a universally-conserved GxxxG motif 
and a pair of polar residues on the same helical face. The conservation of these 
sequence elements, which have been shown in the case of human BNIP3 to be 
critical for TMD dimerization in detergents and membranes [9, 57], suggests that 
the capacity to dimerize may also be conserved across BNIP3 orthologs. 
A BLAST search of the D. melanogaster genome using the HsBNIP3 
transmembrane domain as a criterion yielded the putative gene CG5059, which I 
refer to in this thesis as DmBNIP3, the Drosophila ortholog of BNIP3. The 
sequence bears a striking resemblance to the human BNIP3 ortholog and shows 
a high degree of homology to the BNIP3 TMDs of other lower-order species 
(figure 2.5.1). CeBNIP3, though showing even less identity to the human 
ortholog than DmBNIP3, also maintains the same conserved GxxxG, polar 
residue pair, and small central residue (see Figure 2.5.1). Because of these 
similarities, I hypothesized that DmBNIP3 TMD and CeBNIP3 TMD would both 
demonstrate homodimerization characteristics similar to those observed for 
HsBNIP3. 
Fig 2.5.1 Sequence alignment of BNIP3 ortholog transmembrane domains 
BNIP3 proteins have similar transmembrane domains throughout known ortho-
logues. All contain a GxxxG dimerization motif, a pair of polar residues slightly 
n-terminal of the TMD center, and a small residue (alanine or serine) near the 
center followed by a large hydrophobic residue (motif residues are underlined at 
bottom). Transmembrane domains carrying the Thr-Asn polar residue pair tend 
to carry the small serine, perhaps to provide a second interhelical hydrogen 
bonding partner for the polar asparagine. 
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To investigate this possibility, I first focused on the transmembrane 
domain of the BNIP3 ortholog from Drosophila melanogaster (DmBNIP3). The 
TMD of DmBNIP3 contains a conserved GxxxG dimerization motif when 
compared to HsBNIP3. In addition to the GxxxG, other residues corresponding 
to HsBNIP3 dimerization motif residues [57] are similar to the HsBNIP3 motif, 
including a ThrAsn pairing in place of the human SerHis and a serine in place of 
the small interfacial alanine found in the human protein. Notably, DmBNIP3 
contains a ThrAsn residues pair corresponding to the interhelical hydrogen bond-
forming SerHis pair in the human protein. DmBNIP3 also maintains a small 
residue between the hydrogen-bonding pair and the GxxxG motif. When 
assayed via TOXCAT, DmBNIP3 demonstrated homodimerization strength 
exceeding that of HsBNIP3 and in excess of 250% GpA. Single-residue 
substitutions to the ThrAsn residue pair, however, failed to abrogate dimerization 
to a significant extent in TOXCAT, contrary to their putative function as a dimer-
stabilizing hydrogen-bond pair (figure 2.5.2). Additionally, mutations to the first 
Gly of the GxxxG motif failed to significantly disrupt dimerization (figure 2.5.2), 
indicating that the DmBNIP3 TMD may not possess the same dimerization 
characteristics as the human protein. In contrast to observations in TOXCAT, 
DmBNIP3 also fails to dimerize significantly when expressed as a Staphylococcal 
nuclease construct and run in conditions of SDS-PAGE. This could be due in 
part to the presence of a tyrosine near the N-terminus of the TMD, which may 
increase overall polarity to the extent that partitioning into micelles as a dimer is 
unfavorable. 
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Figure 2.5.2 Mutations to the putative interface of DmBNIP3 fail to abrogate 
dimerization in TOXCAT 
A. The C-terminus of DmBNIP3 with the transmembrane domain underlined. 
The Drosophila melanogaster ortholog of BNIP3 contains a transmembrane 
domain with the putative interface T149NxxSxxxGxxxG161. The putative 
hydrogen-bonding ThrAsn pair is conserved, as well as the small serine and 
c-terminal GxxxG dimerization motif. B. TOXCAT data of DmBNIP3 and six 
substitutions at three interfacial positions. Wild-type DmBNIP3 demonstrates 
very strong self-association in TOXCAT. Single-residue substitutions to the 
putative interhelical H-bonding pair (T149 and N150) failed to disrupt dimerization 
in TOXCAT to any significant extent. Additionally, substitutions to Gly157 (the 
first of two glycines composing a GxxxG dimerization motif) also failed to signfi-
cantly disrupt dimerization, suggesting either that DmBNIP3 homodimerization 
does not rely on these residues or that the reduction in dimerization energy 
caused by these mutations is not enough to disrupt dimerization in TOXCAT. 
50 
I also examined the propensity of the Caenorhabditis elegans BNIP3 
(CeBNIP3) TMD to self-associate. Although this ortholog has less overall 
sequence identity and similarity to HsBNIP3 TMD, it exhibits very similar 
behavior in TOXCAT and SDS-PAGE dimerization assays. Like DmBNIP3, 
CeBNIP3 TMD contains a GxxxG homodimerization motif, a ThrAsn putative 
interhelical hydrogen-bonding pair and small residue between those two features 
and on the same helical face (figure 2.5.1). CeBNIP3 TMD maintains only three 
conserved residues when compared to HsBNIP3 TMD and shows only 33% 
similarity. Like DmBNIP3, CeBNIP3 TMD demonstrates very strong self-
association when assayed in TOXCAT, with reporter gene expression 
approaching that of the Drosophila orthologue and exceeding HsBNIP3 (figure 
2.3). Additionally, unlike DmBNIP3 TMD, the CeBNIP3 TMD forms strong 
homodimers as a Staphylococcal nuclease construct in the conditions of SDS-
PAGE. This permits the examination of sequence specificity in the context of a 
micelle environment and can provide the basis for future structural studies in 
detergents and makes it a more attractive target for further analysis. 
Although the CeBNIP3 TMD is least conserved when compared to the 
human sequence, both sequences form much stronger dimers than the positive 
control GpA in both detergents and membranes. It seems that although the 
sequence of the BNIP3 transmembrane domain has varied greatly through 
evolution, the ability to self-associate has been preserved, suggesting that the 
capacity to form homodimers performs some crucial biological role. I chose to 
investigate the sequence dependence of CeBNIP3 TMD dimerization to 
determine if CeBNIP3 and HsBNIP3 TMDs use similar or different residues and 
structures to drive protein-protein interactions inside membranes. 
2.6 CeBNIP3 TMD and HsBNIP3 TMD do not form heterooligomers in 
detergent 
HsBNIP3 forms strong homodimers in conditions of SDS-PAGE due to 
TMD-mediated self-association [8,101, 102]. The stability of the HsBNIP3 TMD 
interaction relies on a helical interface identified by site-directed mutagenesis and 
consisting of a series of seven amino acids: S172HxxAlxxGlxxG [57]. Similarly, 
CeBNIP3 also forms strong homodimers in detergent mediated by the C-terminal 
end of the protein [12] and I have shown that CeBNIP3 TMD drives strong 
dimerization in a cell membrane (see Section 2.5; Figure 2.3). Despite their 
sequence differences (see Figure 2.5.1), the TMDs may form similar structures 
that could be capable of interacting with one another to form hetero-dimers. 
I used a peptide competition version of the Staphyloccocus nuclease 
dimerization assay to determine if CeBNIP3 TMD and HsBNIP3 TMD could 
interact in detergent. To produce samples of the CeBNIP3 and HsBNIP3 TMD 
peptides, the corresponding SN-fusion proteins were created as described in 
section 2.2 and extracts were purified with salt and detergent extractions and ion 
exchange chromatography in detergent. Aliquots of these samples were 
subjected to trypsin digestion to degrade the Staphylococcus nuclease domain. 
The transmembrane domain peptides were lyophilized and further purified by 
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reversed-phase HPLC, then added to protein samples in an approximate ratio of 
4:1 peptide:protein. The resulting samples were resolved by SDS-PAGE. 
The SN-HsBNIP3 protein forms strong homodimers in detergent (Figure 
2.6, lane 2). When HsBNIP3 TMD peptide is added (lane 3), the homodimer 
band decreases in intensity and a new band corresponding in molecular weight 
to a protein/peptide hetero-oligomer appears. However, when CeBNIP3 TMD 
peptide is added to the SN-HsBNIP3 protein sample (lane 4), no heterodimer 
band forms and the protein homodimer band intensity does not change. 
Similarly, SN-CeBNIP3 protein forms strong homodimers in SDS (lane 7) and the 
addition of CeBNIP3 TMD peptide causes the emergence of a heterodimer band 
(lane 8), the addition of HsBNIP3 TMD peptide (lane 9) does not result in a 
heterodimer band. These results suggest that, though HsBNIP3 and CeBNIP3 
share sequence similarities and both homodimerize tightly in detergent, each of 
these sequences forms a dimer based on interactions that are specific enough to 
exclude heteromeric interactions with the other. Thus, these transmembrane 
domains can effectively discriminate between similar sequences. 
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Fig 2.6 CeBNIP3 TMD and HsBNIP3 TMD do not interact with each other in 
detergent 
HsBNIP3 and CeBNIP3 form strong homodimers in conditions of SDS-PAGE 
(lanes 2 and 7, respectively). The addition of HsBNIP3 TMD peptide to SN-
HsBNIP3 protein causes the emergence of a protein:peptide heterodimer band 
and significant reduction of protein dimer (lane 3), while addition of CeBNIP3 
TMD peptide (lane 4) fails to interact. Similarly, SN-CeBNIP3 protein forms 
strong protein dimers in SDS-PAGE (lane 7) and interacts strongly with CeBNIP3 
TMD peptide (lane 8), but fails to significantly interact with HsBNIP3 peptide 
(lane 9). These results suggest that, depsite their somewhat conserved interac-
tion motifs, the structures of HsBNIP3 and CeBNIP3 TMDs are different enough 
to specifically interact to form only homodimers in detergent. 
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3. Characterization of CeBNIP3 transmembrane domain dimerization in cell 
membranes and in detergent 
3.1 The CeBNIP3 transmembrane domain is sufficient to drive protein 
dimerization in SDS detergent micelles 
Following the procedures described by Lemmon et al., I subcloned the 
CeBNIP3 TMD into a plasmid containing the Staphylococcus nuclease (SNase) 
protein to facilitate protein expression and purification [11]. The resulting fusion 
protein (SN-CeBNIP3) includes residues 169-207 of wild-type CeBNIP3, 
comprising the transmembrane domain and flanking regions, in frame with the C-
terminal end of SNase. This plasmid was transformed into the E. co//expression 
line BL21(DE3), from which protein could be expressed and purified in significant 
quantities by previously described protocols [9, 11, 57, 139]. 
Expressed and purified SN-CeBNIP3 migrates in SDS-PAGE at 
approximately 45 kD, twice the molecular weight predicted for a SN-CeBNIP3 
monomer (figure 3.1, panel A), indicating that the majority of SN-CeBNIP3 is 
homodimeric in SDS. To confirm that this homodimer is mediated by the 
transmembrane domain, peptide corresponding to the CeBNIP3 TMD was added 
to SN-CeBNIP3 and the mixture resolved on SDS-PAGE (figure 3.1, panel B). 
This procedure has been previously shown to result in the emergence of 
protein/peptide heterodimers when applied to glycophorin A, HsBNIP3, and 
Syndecan-2 [9, 11, 139]. The intensity of the SN-CeBNIP3 homodimer band 
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Figure 3.1 CeBNIP3 TMD drives homodimerization in SDS micelles 
A. Immunoblotting of CeBNIP3 in SDS-PAGE reveals concentration-dependent 
homodimerization. CeBNIP3 TMD reaches a dimermonomer equilibrium at 
approximately 30nM, indicating very strong dimerization. Higher protein concen-
trations increase the propensity to form homodimers. B. CeBNIP3 TMD 
dimerization in SDS-PAGE is reversible. Increasing concentrations of CeBNIP3 
TMD peptide were added to SN-CeBNIP3, causing the emergence of a protein-
peptide heterodimer band. 
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decreases in direct relation to the amount of CeBNIP3 TMD peptide added, and 
a new band of intermediary apparent molecular mass appears (~24kD). 
Because this migration is consistent with the mass of SN-CeBNIP3 plus one 4 
kDa peptide, I assign this band to be a SN-CeBNIP3/peptide heterodimer. 
Unlike all other sequenced BNIP3 orthologs, CeBNIP3 contains a cysteine 
at the C-terminal end of its transmembrane domain (figure 2.5). Cysteines have 
been demonstrated to have varying purposes in proteins, including the formation 
of covalent disulfide bonds, roles in association with biological membranes, to 
maintaining particular protein folds, and serving as a site for the addition of post-
translational modifications to perform myriad biological functions. One interesting 
function of cysteines has been identified in SNARE proteins, wherein one or 
more cysteines between the N-terminal end of the TMD and the cytoplasmic 
domain is modified by post-translational palmitoylation, which then may function 
to prevent ubiquitination and degradation of the protein [144]. A literature search 
reveals no such function in the BH-3 protein family or even the existence of TMD-
related cysteines in the Bcl-2 superfamily. Furthermore, no other known BNIP3 
orthologs retain a cysteine in their transmembrane domains. Thus, it seems 
unlikely that the cysteine located in the ceBNIP3 TM domain functions in any 
post-translational protein modification or cellular process. 
To eliminate the possibility of a disulfide bond being the primary cause of 
stable dimerization in detergent, I mutated the cysteine at position 198 to serine, 
another slightly polar amino acid of comparable size, and observed no change in 
the propensity of CeBINP3 TMD to form dimers (the C198S clone was used for 
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all further mutagenic studies). I conclude from these data that the CeBNIP3 TMD 
drives reversible homodimerization in SDS-PAGE, and that this interaction does 
not depend on disulfide formation. 
3.2 CeBNIP3 TMD homodimerization in SDS-PAGE is sequence-dependent 
Interactions of transmembrane proteins frequently occur via 
extramembranous domains. In the Bcl-2 protein family, a majority of interactions 
have been determined to occur through interactions mediated by conserved Bcl-
2 homology domains [78, 82-86] and solution structures of Bcl-2 homologs 
identify a hydrophobic ligand-binding groove capable of binding peptides found in 
other proapoptotic mediators [85]. Furthermore, biochemical and structural 
studies have found that BH3 domains can interact with other Bcl-2 homology 
domains by adopting an a-helical structure [86]. The homodimerization function 
of BNIP3 proteins has been shown to be mediated by the transmembrane 
domain [101]. Endah Sulistijo analyzed the BNIP3 TMD by saturation 
mutagenesis, identifying a six-residue helical interface responsible for 
dimerization in detergent [9, 57]. Additionally, the structure of the BNIP3 TMD 
confirms the interface identified by mutagenesis [121][Endah Sulistijo, manuscript 
submitted]. BNIP3 proteins share conserved elements across species (figure 
2.5), including a GxxxG dimerization motif, a pair of polar residues, and a small 
amino acid separating those two elements. These conserved residues all fall 
upon one face of the transmembrane helix. Solution structures have shown that 
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the polar residues Ser172 and His173 come into close-enough proximity to form 
an interhelical hydrogen bond [Endah Sulistijo, manuscript submitted]. The 
GxxxG motif permits close association of the two helices and increases the 
number of close packing interactions formed by adjacent residues [Endah 
Sulistijo, manuscript submitted]. Residues comprising the HsBNIP3 interface are 
conserved or similar in CeBNIP3, suggesting a similar set of interactions may 
drive CeBNIP3 TMD self-association. 
To determine the sequence specificity of CeBNIP3 homodimerization in 
detergents, I created a collection of single residue substitutions along the length 
of the CeBNIP3 TMD in the SN-CeBNIP3 fusion protein. Mutant proteins were 
expressed and purified for analysis in SDS-PAGE for dimer:monomer ratios by 
Coommassie staining or immunoblotting. Single residue mutations showed an 
assortment of abrogative effects, with disruptive substitutions situated on the C-
terminal half of the TMD (figure 3.2). Important residues were observed to be 
situated on the same face of the a-helical transmembrane domain, suggesting an 
interaction surface similar to those observed in such proteins as HsBNIP3 and 
GpA. Mutations to residues away from this helical face or more N-terminally 
situated than Ser186 failed to disrupt dimerization in an SDS-PAGE environment. 
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Figure 3.2 Schematic representation of the effects of single-residue substi-
tutions on CeBNIP3 homodimerization in SDS-PAGE 
Single-residue substitutions disrupt the ability of CeBNIP3 TMD to form homodi-
mers to varying degrees. The wild-type CeBNIP3 TMD sequence is located at 
the top of the chart, with substitutions forming the left column. Mutations to the 
residues Ser186, Phe187, Gly190, Gly194, and Ser198 tend to greatly disrupt 
dimerization, suggesting this face of the helical TMD comes into close contact 
during homodimerization. Gly194 is the least tolerant to mutation and may repre-
sent the crossing point of the helices when inserted into an SDS micelle. 
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3.3 CeBNIP3 TMD self-association in detergent is driven by an interface 
containing a GxxxG dimerization motif 
Many self-associating transmembrane domains contain at least one 
GxxxG motif [9, 63, 137, 139, 145-149], suggesting that this motif plays a 
common role in TMD homodimerization. The glycines in a transmembrane 
domain GxxxG motif form a channel-like surface that permits the close 
interaction of molecules and dimer stabilization using Van der Waals contact 
surfaces [39, 150]. Mutations of either or both of these glycines to larger 
residues frequently results in the abrogation of dimerization due to steric clashes 
arising between large sidechains that cannot be incorporated spatially by the 
structure in the context of a dimer [150]. The close approach of transmembrane 
helices made possible by a GxxxG can be stabilized by adjacent larger 
hydrophobic residues, as supported both by biochemical and structural data [39, 
63,121]. In addition to these interactions, studies have suggested that 
transmembrane domain associations, particularly those between right-handed 
parallel TMDs containing GxxxG motifs, may be stabilized by interhelical 
hydrogen bonding between Coc hydrogens and carbonyl oxygen atoms of the 
opposite monomer [151]. Sidechain-sidechain hydrogen bonds have also been 
shown to stabilize TMD interactions, as is the case with human BNIP3 [57,121]. 
While a GxxxG motif may indicate that a TMD self-associates, the identity 
of nearby residues are also important to enable dimerization motifs to be 
correctly recognized from primary protein structure. Residues adjacent to a 
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GxxxG motif have been shown to stabilize association of transmembrane helices 
in detergents [37, 57]. In order to increase the chances of finding all residues 
participating in CeBNIP3 TMD dimerization, I undertook limited scanning 
mutagenesis, in which I substituted each wild-type residue with phenylalanine, 
leucine, and isoleucine. These residues are commonly found in transmembrane 
domains and possess sidechains bulky enough that they would be expected to 
cause disruption of helix-helix interactions unless they were situated away from 
the dimer interface [42]. 
Single residue substitutions that disrupt CeBNIP3 homodimerization are 
restricted to the C-terminal side of the transmembrane domain; mutations N-
terminal to Ser186 generally fail to disrupt dimerization significantly (figure 3.2). 
One exception to this observation is a substitution of phenylalanine at Gly178, 
which resulting in a slight decrease of dimerization, resulting in a dimerization 
phenotype between 50-75% of wildtype. Although this is a significant decrease 
in self-association, the failure of other mutants at this position to disrupt self-
association and lack of any effects at adjacent residues suggests that this effect 
is due to an unrelated artifact; the presence of the Phe may affect the interaction 
between the CeBNIP3 TMD and the micelle. 
The association interface of CeBNIP3 TMD as determined by site-directed 
mutagenesis in an SDS-PAGE environment is formed by the residues 
S186FxxGxxxGxxxS (figure 3.2). These residues fall onto a single helical face of 
the CeBNIP3 transmembrane domain to form a dimeric interface. The alanine 
residue at position 191 may also contribute somewhat to dimerization. 
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The GxxxG motif that is conserved in all BNIP3 protein transmembrane 
domains (figure 2.5) is formed by the two glycines found at positions 190 and 194 
in CeBNIP3. As in other BNIP3 proteins, the GxxxG motif of CeBNIP3 is situated 
toward the C-terminal end of the transmembrane domain. Single-residue 
substitution mutations at each glycine position reveal that CeBNIP3 self-
association depends on the presence of this GxxxG motif. Though I focused 
primarily on large residues as substitutes due to their greater ability to cause 
steric clashes, I also acquired several substitutions to small residues at the Gly 
190 position. 
My results show that substitutions at Gly 194 completely abrogate 
CeBNIP3 TMD dimerization in SDS-PAGE in all observed cases (figure 3.3.1, 
panel A). I created mutations substituting Gly 194 with Phe, Val, Leu, and lie at 
this position and in each case the single residue substitution resulted in the 
disappearance of the 45 kD homodimer band and the emergence of a dominant 
24 kD monomer. 
Contrary to observations of Gly 194 mutants, substitutions at the Gly 190 
position yield a variety of phenotypes (figure 3.3.1, panel B). The G190F 
mutation completely disrupts dimerization in SDS, a result mirroring that seen by 
the same mutation at position 194. However, changes to residues smaller than 
the bulky phenylalanine result in lesser degrees of abrogation. Isoleucine and 
leucine both cause nearly complete disruption, and mutation of Gly 190 to valine 
causes even less disruption to dimerization, suggesting that the helical packing 
around this glycine brings the two monomers close enough to create favorable 
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Figure 3.3.1 The GxxxG motif is critical to CeBNIP3 homodimerization in 
SDS 
A. Homodimerization in detergent relies heavily on the Gly194 residue, as all 
substitutions made to this position completely disrupt dimerization in SDS. Due 
to its intolerance of substitutions and position within the TMD interaction surface, 
Gly194 may be the crossing point of two interacting helices. B. Gly190 also 
plays a significant role in CeBNIPS TMD dimerization in micelles. Substitution to 
Phe reduces dimerization entirely, while substitutions to slightly smaller residues 
leave traces of dimerization. 
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packing interactions but retains enough distance to accommodate some larger 
hydrophobic residues. 
The residues that make up the CeBNIP3 dimerization interface are 
identical or chemically similar in all BNIP3 sequences. Though some mutations 
are tolerated to varying extents at the Gly 190 position of CeBNIP3 retain a 
degree of dimerization function, whereas all mutations at Gly 194 abolish 
dimerization and these glycines are conserved in every BNIP3 sequence (see 
Figure 2.5). From these data, I conclude that the GxxxG motif of CeBNIP3 TMD 
is essential to its ability to form stable homodimers in SDS micelles, and that Gly 
194 is the more important of these two glycines. 
Ser 186 of the CeBNIP3 TMD is conserved as either a serine or alanine in 
all known BNIP3 orthologs: all known sequences have a small residue at this 
position. Accordingly, mutations at position 186 cause substantial reductions to 
homodimer stability in an SDS micelle (Figure 3.3.2). The S186L mutation 
causes the most substantial observed abrogative effect and completely disrupts 
dimerization when assayed in detergent. Phenylalanine and isoleucine 
substitutions also demonstrate a high level of disruption with each resulting in a 
loss of dimer band intensity to 25-50% of wildtype. These substitutions seem to 
defy conventional interpretations of sidechain roles in dimerization, as these 
larger or more rigid sidechains have a less disruptive effect than the shorter 
(compared to Phe) or more flexible (compared to lie) substitution to leucine. 
Interestingly, a valine mutation at this position is reasonably well tolerated (75% 
dimer). 
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Fig 3.3.2 Mutations at the Ser186 and Ser198 positions significantly abro-
gate dimerization in SDS-PAGE 
A. CeBNIP3 TMD is largely intolerant of mutations at the Ser186 position, as 
substitutions to large non-polar amino acids generally result in total or near-total 
reductions in dimerization. Interestingly, though intolerant of a substitution to 
isoleucine, substitution to valine only minimally abrogates dimerization. B. The 
Ser198 position is completely intolerant of mutations significantly larger than the 
wild-type residue, suggesting a close interaction with a partner helix subject to 
spatial restraints in micelles. Mutations to smaller and similar residues are toler-
ated. 
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Phenylalanine 187 appears to also play a role in CeBNIP3 TMD 
dimerization. Substitution to ^-branched sidechains such as isoleucine or valine, 
which are locked into a single x1 rotamer in helices, disrupt dimerization 
significantly (figure 3.3.3). In contrast, a leucine substitution supports 
dimerization, suggesting that a large sidechain can be accommodated if it is free 
to rotate about the Ca-Cp bond to adopt a position that does not clash with the 
opposite monomer. Additionally, mutation to a small glycine residue disrupts 
dimerization, suggesting that the large sidechain of the native phenylalanine may 
participate in favorable packing with the opposite monomer to enhance dimer 
stability. Interestingly, however, substitution with a tyrosine residue also 
abrogates dimerization (figure 3.3.3), perhaps suggesting that the hydrophobicity 
contribution of phenylalanine participates in the ability of CeBNIP3 to interact 
favorably with the micelle environment and explaining the abrogative effect of 
some more polar mutations. 
The CeBNIP3 TMD extends four additional amino acids beyond the 
GxxxG toward the C-terminus in comparison to the human ortholog, creating an 
extra turn of helix after the canonical dimerization motif. Position 198, which 
rests upon the same helical face as the critical glycines 190 and 194, can 
accommodate residues of similar physical size as the wildtype cysteine (figure 
3.3.2, panel B), but mutations to residues larger than serine significantly affect 
dimerization. Substitution to threonine is somewhat tolerated, as this mutation 
reduces dimerization to about 75% of wild-type. Interestingly, mutation to alanine 
Fig 3.3.3 Phenylalanine 187 participates in CeBNIP3 TMD homodimer 
stability in SDS 
Mutations to the phenylalanine at position 187 show a tendency to disrupt 
dimerization in detergents. Interestingly, the F187L mutation (not shown) demon-
strates near wild-type dimerization. This might suggest that the flexible sidechain 
of leucine is able to fulfill the stabilizing role normally performed by phenylalanine, 
while rigid p-branched sidechains disrupt the interaction. 
results in wildtype level dimerization but a glycine substitution eliminates the 
ability to CeBNIP3 to self-associate in detergent. Although the disruptive effects 
of bulky substitutions can be rationalized in terms of steric clashes, and the polar 
Y atom of Cys/Ser/Thr is dispensable, the disruptive effect of mutation to glycine 
at position 198 is difficult to explain. It may be that the observed disruption by 
glycine is an artifact of the detergent environment. However, it is noteworthy that 
most BNIP3 orthologs that closely resemble CeBNIP3 have a serine, threonine, 
or alanine at this position. (The one exception is Anopheles gambiae, which has 
a glutamine in this position.) 
While the GxxxG motif is critical to homodimerization as determined by 
mutational analysis, positions 186 and 198 also seem to play a role in CeBNIP3 
TMD self-association. Dimerization relies upon these elements as well, and so 
together these data suggest an interhelical interaction motif located at the C-
terminal end of the transmembrane domain and consisting of residues 
si86Fi87xxGi9oxxxGi94xxxC/si98 A | a 1 9 1 m ay also contribute to homodimer 
specificity in SDS, as a substitution to phenylalanine at this position causes a 
significant loss of dimerization (25-50% wild-type), though other mutations fail to 
disrupt. 
When compared to the dimerization interface of HsBNIP3 TMD identified 
by Sulistijo [57], the CeBNIP3 interface is somewhat different. While both 
dimerization interfaces encompass the C-terminal end of the transmembrane 
domain, HsBNIP3 TMD dimer stability relies heavily on the polar residues Ser 
172 and His 173. Similar residues exist in CeBNIP3 TMD, which contains the 
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polar residue pair Thr 182 and Asn 183. Contrary to observations in the human 
ortholog, however, these residues are not necessary for CeBNIP3 dimerization in 
SDS. This may mean that the helices do not come into close enough proximity in 
this area to facilitate interhelical hydrogen bonding, or it may be that the 
hydrogen bonding occurs but has no significant energetic contribution to stability, 
such that loss of the interaction does not adversely affect dimerization. 
3.4 TOXCAT constructs containing CeBNIP3 TMD insert properly into the cell 
membrane and demonstrate strong association 
Detergents are necessary to extract, solubilize, and purify proteins that 
contain strongly hydrophobic transmembrane helices. Although functional 
assays and measurements of protein-protein interactions can be readily 
performed in detergent environments, and detergents simplify (or are essential 
for) some biochemical and structural experiments, such studies cannot be 
guaranteed to accurately mimic the conditions found in a biological membrane. 
To determine if the TMD interactions identified in the preceding sections occur 
under physiologically and biologically relevant conditions, I have examined the 
self-association of the CeBNIP3 transmembrane domain in a true cell membrane 
using the TOXCAT assay (described in section 1.4). 
The E. coli cell membrane into which the TOXCAT fusion protein is 
inserted is similar to the mitochondrial outer membrane with which CeBNIP3 
associates in vivo. The outer membrane of the mitochondrion encompasses the 
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entire organelle and disruption of this membrane can result in cell death [152]. 
The lipids of mitochondrial outer membranes vary across species but consist 
primarily of a combination of phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylinositol, and cardiolipin [153-155] constituting a membrane of 
thickness ranging from 60-70 A [156, 157]. Contrary to mitochondria, bacterial 
membranes contain a wide variety of membrane phospholipids of varying 
saturation, due in part to their ability to adapt membrane fluidity to external 
temperature and other conditions [158,159]. Their component phospholipid 
headgroups, though, are somewhat similar to those of mitochondria, consisting 
mostly of phosphatidylethanolamine with inclusions of cardiolipin, phosphatidic 
acid, and phosphatidylglycerol [160] with an average thickness of around 50-55 
A [161]. Thus, the headgroup region of the bacterial cell membrane will be of 
similar composition to the mitochondrial outer membrane, but there may be a 
significant discrepancy between the thicknesses of the native membrane in which 
CeBNIP3 normally resides and the assay membrane. Differences in the 
thickness of the hydrophobic region of the bilayers may alter the ability of the 
TMD to make lateral contacts: for instance, a long TMD might have to tilt 
considerably to fit into a smaller bacterial membrane without exposing the 
hydrophobic TMD residues to the aqueous phase. However, the minimal 
differences between E. coli and the mitochondrial outer membrane suggest that 
as long as the ToxR-TMD-MBP fusion protein is correctly incorporated into the E. 
coli inner membrane, the TOXCAT assay should be appropriate for examining 
CeBNIP3 TMD dimerization. 
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The CeBNIP3 TMD was cloned into the TOXCAT expression plasmid 
resulting in the in-frame fusion construct ToxR-CeBNIP3 TMD-MBP. To ensure 
proper membrane insertion, malE cells containing this TOXCAT construct were 
plated onto M9-minimal media containing 0.4% maltose as the single carbon 
source. Cells carrying the CeBNIP3 TMD TOXCAT plasmid grew successfully 
on maltose plates, whereas controls lacking a transmembrane domain or vector 
failed to grow (figure 3.4 panel A). The CeBNIP3 TMD drives very tight 
homodimerization of the ToxR-TMD-MBP construct in cell membranes (figure 
3.4, panel B). 
3.5 Saturation mutagenesis of CeBNIP3 TMD reveals self-association relies 
on a GxxxG motif and potential interhelical hydrogen bonding 
Analysis of CeBNIP3 TMD homodimerization in SDS-PAGE identified an 
interaction motif critical to CeBNIP3 TMD homodimerization in detergent. To 
investigate the potential biological relevance of this interface, I performed 
saturation mutagenesis on the CeBNIP3 TMD in the TOXCAT system. I created 
a series of single-residue substitutions over the entire length of the CeBNIP3 
transmembrane domain and assayed the effects on homodimerization using 
TOXCAT (described in section 2.1). I made TOXCAT measurements on three 
independent cultures for each mutant examined, and each culture was assayed 
in triplicate. CAT activities for mutant TMDs were normalized to the value for the 
wildtype CeBNIP3 TMD and are reported in Appendix 1, and these scaled values 
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Fig 3.4 CeBNIP3 expressed in the TOXCAT assay inserts properly into the 
cell membrane and drives strong TOXCAT expression 
A. CeBNIP3 (C198S), the clone used as "wildtype," complements maltose, 
indicating proper insertion of the TMD construct into the cell membrane. Alterna-
tively, negative controls such as CD40 (a transmembrane domain containing a 
stop codon), pccKAN (the TOXCAT plasmid with an interrupting kanamycin 
resistance gene), and NT326 (untransformed TOXCAT expression cells) fail to 
grow on maltose. Other mutants of CeBNIP3 also grow on maltose plates. B. 
When expressed in TOXCAT, both CeBNIP3 and the non-cysteine clone 
CeBNIP3 (C198S) drive dimerization in a cell membrane. Additionally, both 
greatly exceed the reporter gene expression demonstrated by the Glycophorin A 
positive control. The C198S mutation was created to prevent the possibility of 
any apparent homodimerization being driven by an interhelical covalent disulfide 
bond. 
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were converted to bins for the purposes of constructing figure 3.5.1. Although 
the values of CAT activity recorded for different mutants vary almost 
continuously, I chose to use bins to classify the mutations because of the 
possibility that small differences in the expression level of the ToxR-TMD-MBP 
fusion protein might be affecting the final reporter gene measurements. Because 
western blots indicate that the fusion protein levels are invariably within a factor 
of 2,1 used bins whose limits are separated by somewhat less than a factor of 2. 
Mutations that showed more than 55% of wildtype CAT activity were termed 'not 
disruptive', those showing 31%-55% of wildtype CAT activity were classified as 
'slightly disruptive', those showing 17%-31% of wildtype CAT activity were 
termed 'mostly disruptive', and those exhibiting less than 17% of wildtype CAT 
were placed in the bin 'disruptive'. 
The TOXCAT scanning mutagenesis data reveals a pattern of 
abrogation by mutations to the residues Thr 182, Asn 183, Ser 186, Phe 187, Gly 
190, and Gly 194 (figure 3.5.1). Nearly all mutations to Gly 190 greatly disrupt 
dimerization in membranes. Substitutions to any large hydrophobic residue 
including Phe, He, and Leu result in dramatically reduced association (< 5 % of 
wildtype CeBNIP3 TMD levels), resulting in TOXCAT signal levels at or below the 
GpA-G83l negative control (Figure 3.5.2). Interestingly, mutating Gly 190 to 
alanine is tolerated by CeBNIP3 TMD, diminishing dimerization signal only by 
about 50%. Mutational and structural analysis of HsBNIP3 in detergents shows 
that the corresponding glycine in the human ortholog is located at the very center 
of the crossing helices and contains no room to accommodate mutation [121], a 
180 190 
Figure 3.5.1 A schematic representation of homodimer disruption in 
TOXCAT caused by single residue substitutions in CeBNIP3 TMD 
Single-residue substitutions were created in the CeBNIP3 transmembrane 
domain and examined for abrogative effects in the context of the TOXCAT assay. 
Similar to results seen in SDS-PAGE, the GxxxG motif is largely intolerant of 
mutation, though unlike detergents, the glycine at position 190 seems more 
sensitive to substitutions than Gly194. Additionally, while Asn182 appears to play 
a significant role in self-association, mutations at Ser198 have no abrogative 
effect. Mutagenesis results in TOXCAT suggest a helical interaction face contain-
ing the residues N183xxSFxxGxxxG and indicate a variation in the dimeric struc-
ture in membranes than detergent micelles. 
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Figure 3.5.2 The GxxxG motif is critical to CeBNIP3 TMD homodimerization 
in TOXCAT 
CeBNIP3 TMD contains a GxxxG interaction motif that drives dimerization in a 
cell membrane. When assayed in TOXCAT, substitutions at the G190 postion 
have a severe abrogative effect on TMD-mediated self-association. Mutations to 
G194, while less severe, also disrupt dimerization to a significant extent. The 
severity of disruption due to mutations at position 190 compared with position 
194 suggests that, in the context of a cell membrane, G190 is the point of helix-
helix crossing in a CeBNIP3 TMD homodimer 
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result supported by mutational analysis in SDS [57]. Though AxxxG is 
considered a dimerization motif in transmembrane helices [162], structural 
models suggest that any larger residue replacing the central glycine in HsBNIP3 
will induce clashes and disrupt essential close packing interactions. 
Mutations at Gly 194 have less severe effects on dimerization in 
membranes than those at Gly 190. The most disruptive mutation observed at 
this position is to leucine, which results in less than 10% of wildtype reporter 
gene expression, but all large residue substitutions diminish TOXCAT signal 
greatly (figure 3.5.2). However, mutations to small sidechains have more modest 
effects. Substitution at this position to alanine fails to disrupt dimerization to any 
significant extent, suggesting that Gly 194 does not play as critical a role jn 
dimerization as Gly 190. This in turn supports the idea that, similar to 
observations in the HsBNIP3 TMD dimer structure, Gly 190 represents the point 
of helix crossing. 
Though somewhat tolerant of mutations, Ser 186 appears to participate in 
dimer stability to a significant extent in a cell membrane. Substitutions to amino 
acids with bulky sidechains result in reduced dimer stability, though the extent of 
disruption varies (figure 3.5.3). Similar to my observations of mutations at Gly 
194, mutation to a leucine at the Ser 186 position causes the most extreme 
disruption to dimerization and results in only 20-30% of wildtype dimerization 
levels. Other substitutions to larger residues like isoleucine and phenylalanine 
also cause reductions in dimer stability, though to a lesser extent (40-60% of 
wildtype). Mutations to smaller residues fail to disrupt dimerization to any 
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Fig 3.5.3 Serine186 and Phenylalanine 187 contribute to CeBNIP3 homodi-
mer stability in TOXCAT 
Similar to results observed in SDS-PAGE, the residues Ser186 and Phe187 
contribute to dimer stability in a cell membrane. Abrogation of the dimer is not as 
severe as that observed in detergent, however, and may suggest that transmem-
brane domains in lipid bilayers are forced to accommodate less-favorable interac-
tions due to an inability to flex and break the helix in response to certain substitu-
tions. 
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significant extent. Interestingly, substitution with threonine also fails to disrupt 
dimerization, indicating the possibility that the retention of a sidechain hydroxyl 
group plays a role in dimer stability. Solution structures of the human BNIP3 
ortholog show that the Ser 172 and His 173 residues contained in the TMD come 
into close enough proximity to support interhelical hydrogen bonding [121][Endah 
Sulistijo, manuscript submitted]. Furthermore, mutational analysis supports the 
idea that the hydroxyl group of serine participates in dimerization, as 
substitutions to threonine have a greatly reduced abrogative effect when 
compared to substitutions to similar residues (i.e. valine) lacking this sidechain 
element [57, 163, 164]. This supports the idea that polar residues in a 
transmembrane domain can assist in stabilizing lateral interactions in a cell 
membrane [163-166]. 
In addition to the participation of Ser 186 in CeBNIP3 dimerization, the 
adjacent Phe 187 appears to contribute to dimer specificity in a cellular 
membrane. Itself a large hydrophobic residue, limited mutational analysis 
demonstrates that alterations to this position result in reduced dimer stability 
when analyzed in TOXCAT (Figure 3.5.3). Substitutions with leucine or 
isoleucine cause a reduction in dimer stability in the membrane to 50-60% of 
wildtype levels, though valine is accommodated without significant abrogation. 
Past studies have suggested that certain hydrophobic residues are favored at 
locations adjacent to interaction motif residues in the context of certain TMD 
sequences because of the stabilizing effect of large hydrophobic sidechains on 
an otherwise less stable dimer (though phenylalanine itself was not included in 
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sequences tested) [63], providing a possible explanation for the participation of 
Phe 187 in CeBNIP3 homodimerization. 
The residue at position 198 plays an essential role in CeBNIP3 TMD 
homodimerization in detergent, and any substitution to a residue of a significantly 
different size causing total abrogation of the protein dimer. Dimer stability in 
detergent requires a mid-sized sidechain at this position, as a mutation to glycine 
destabilizes dimerization completely (though as previously mentioned, the 
abrogation due to a glycine substitution could also be an artifact of the detergent 
environment). Mutations to position 198 in TOXCAT fail to significantly reduce 
dimerization, however. A scan of mutants to large hydrophobic residues such as 
Leu, Phe, and lie, all of which demonstrated complete disruption of dimerization 
in SDS-PAGE, show no tendency to disrupt association of dimerization in a cell 
membrane. A mutational scan of nearby residues 195-197 also failed to show 
any disruptions to dimerization, suggesting that neither the C-terminal end of 
CeBNIP3 TMD in general nor position 198 in particular participates in TMD 
homodimer stability in the context of a cellular membrane. On a broader topic, 
these results indicate that the CeBNIP3 TMD homodimerizes differently in 
TOXCAT than in detergent and may have implications for the use of detergents 
when analyzing protein-protein interactions. 
Substitutions to Asn 183 reveal that this residue is an important participant 
in dimerization within a cell membrane. Nearly all amino acids tested resulted in 
a significant decrease in overall homodimerization, with the most significant 
reductions resulting from substitutions to non-polar residues. Of note is that a 
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substitution to phenylalanine resulted in no significant loss of dimerization ability 
(figure 3.5.4), suggesting that the asparagine residue may be important in part 
due to its size in addition to its strongly polar nature; however, it is also possible 
that the large Phe sidechain makes packing interactions that compensate for the 
loss of the polar interactions supported by Asn. Conversely, changes to other 
large hydrophobic residues such as leucine and isoleucine resulted in a notable 
loss of dimerization whereas small residue substitutions like glycine and alanine, 
though still disruptive, had more modest effects. Mutations to polar residues 
such as glutamine and histidine (the latter Is found in HsBNIP3 at this position) 
supported dimerization. Though dimerization is maintained with a phenylalanine 
substitution, the results seem to suggest that greater polarity at this position 
increases the propensity of the TMD to self-associate in the membrane and that 
strong dimerization is facilitated by a large flexible sidechain. 
In contrast to the observations at Asn 183, most substitutions at the Thr 
182 position fail to reduce dimerization to any substantial degree. Substitution to 
aspartic acid does diminish dimerization, though this is likely due to the 
significant increase in polarity resulting from this mutation. Of substitutions not 
dramatically altering the overall hydrophobicity of CeBNIP3 TMD, only changes 
to phenylalanine, cysteine, and glycine had a significant abrogative effect. 
Mutations to other nonpolar residues of varying physical size did not compromise 
homodimer stability (figure 3.5.4), suggesting that Thr 182 does not play an 
essential role at the CeBNIP3 homodimer interface. 
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Fig 3.5.4 Asparagine182 functions in CeBNIP3 homodimerization in 
TOXCAT 
Mutations to Asn183 significantly disrupt homodimerization of CeBNIP3 trans-
membrane domain in cell membranes. Structural and mutagenesis studies of 
HsBNIP3 suggest that the conserved pair of polar residues present in BNIP3 
TMDs forms interhelical hydrogen bonds, stabilizing the structure. While substi-
tutions at Asn183 disrupt the ability of CeBNIP3 to form strong homodimers in 
TOXCAT, mutations to Thr182 fail to abrogate CeBNIP3 TMD dimerization to a 
significant extent. Thought this may be because Thr182 and Asn183 do not form 
interhelical hydrogen bonds, another possibility is that in the absence of hydro-
gen bonding with Thr182, the Asn183 sidechain is able to form an interhelical 
bond with Ser186, which would account for the observed conservation of both 
throughout lower-order BNIP3 orthologs. 
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From these results, I conclude that, contrary to expectations based upon 
observations made in HsBNIP3, Thr 182 does not participate in CeBNIP3 TMD 
homodimers. However, Asn183 plays an active role in stability and is largely 
intolerant of substitutions. Mutational data of HsBNIP3 TMD and structural 
observations suggest that Ser172 and His173 form interhelical hydrogen bonds 
at the dirtier interface [57,121][Endah Sulistijo, manuscript submitted]. The 
corresponding residues in CeBNIP3 are Thr182 and Asn183, and both residues 
are highly conserved in many species. However, contrary to HsBNIP3 and other 
orthologs containing an alanine at the 176 position (between the hydrogen-
bonding pair and the GxxxG motif), CeBNIP3 and many other species with the 
ThrAsn pairing contain serine instead. One possible explanation for this is that, 
while threonine does indeed participate in hydrogen bonding between helices, if 
that position undergoes a mutation, the asparagine residue may create an 
alternate interhelical hydrogen bond with Ser 186. Such an explanation would 
account both for the persistence of a serine when the Thr-Asn pairing is 
observed and for the conservation of the Thr-Asn residue pair. This explanation 
could also account for the total conservation of the ThrAsn residue pair 
throughout lower-order orthologs in conjunction with the near total conservation 
of the small serine residue in these same orthologs, while also explaining the 
lack of an abrogative effect of substitution at the Thr 182 position while Ser186 is 
maintained. 
From these data, I conclude that hdmodimerization of the CeBNIP3 
transmembrane domain in membranes is mediated by an interaction surface 
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formed by the residues N183xxSFxxxGxxxG. In addition to these residues Thr 
182 may play a role in dimer stability, though single residue substitution 
mutagenesis does not reveal its role in CeBNIP3 TMD self-association. 
3.6 CeBNIP3 TMD demonstrates alternate homodimerization specificities 
when assayed in TOXCAT and SDS-PAGE 
The behavior of proteins in detergent is crucial to biochemical and 
biophysical studies for a number of reasons, not the least of which is the 
assumed biological relevance of protein-protein interactions. Protein interaction 
specificities have been investigated thoroughly for many years in detergents and 
biological implications are assumed from the result. In 2006, Endah Sulistijo 
showed by substitution analysis in SDS detergent that the serine/histidine amino 
acid pair of the HsBNIP3 transmembrane domain formed interhelical hydrogen 
bonds that serve to stabilize dimerizing transmembrane domains [57]. 
Additionally, Bocharov et al published an NMR structure in 2007 of HsBNIP3 
transmembrane domains forming homodimers in lipid bicelles [121]. The 
structure of HsBNIP3 corresponds with data gathered from mutational studies, 
indicating that the interaction studies carried out in detergents are in agreement. 
However, whether or not structures solved in detergent are exactly as occurs in 
nature is largely untested. 
When examining CeBNIP3 in detergent, a distinct dimerization interface 
emerges consisting of S186FxxGxxxGxxxS198 (and also may include Ala 191; see 
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section 3.3). However, examination in TOXCAT yields the dimerization interface 
N183xxSFxxGxxxG (figure 3.4), an N-terminal shift of three residues and a result 
more in accordance with observations in the human BNIP3 ortholog. 
Examination of structure seems to support the interface observed in TOXCAT, as 
substitution of CeBNIP3 residues onto the structure of HsBNIP3 results in a 
comparable structure that potentially fits together in a similar way. Additionally, 
micelles permit protein states that cannot occur in the confines of a lipid bilayer -
for instance, a polar sidechain might cause a helix to flex or bend in the middle, 
exposing that sidechain to the hydrophilic micelle surface. Though detergents 
are a very useful tool, permitting biochemical and biophysical studies that are 
currently impossible in the confines of a living cell, my results suggest such 
interactions must be probed in the context of a biological environment for 
confirmation. 
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4. A combinatorial approach to understanding the role of weakly conserved 
BNIP3 interfacial residues in the stability and specificity of helix-helix 
interactions 
In Chapter 3,1 identified the residues responsible for dimerization of the 
TMD of CeBNIP3 in detergents and in membranes. Aligning the CeBNIP3 TMD 
sequence with that of HsBNIP3 suggests that the interfacial residues of these 
distantly related sequences have retained some similar characteristics: a pair of 
polar residues, a small residue, and a GxxxG motif, at the appropriate spacing to 
lie on one face of a helix. Although these sequences each form homodimers in 
SDS-PAGE, they show no tendency to interact with one another in a peptide 
competition SDS-PAGE assay (see Section 2.6). This suggests that the TMD 
sequences associate specifically: the GxxxG motif does not drive the two TMDs 
to interact promiscuously; rather, residues outside the GxxxG motif must create a 
preferential set of protein-protein interactions. Strictly speaking, this specificity 
could arise from any combination of residues in either of the TMD helices. 
However, my scanning mutagenesis data for CeBNIP3 and the previously 
published mutagenesis data for HsBNIP3 support a role for a limited number of 
interfacial residues in homodimerization, and I hypothesize that these residues 
are also likely to be the primary players in determining interaction specificity. 
To explore the role of weakly conserved interfacial residues from 
CeBNIP3 and HsBNIP3 in dimerization, I used a combinatorial approach to 
generate hybrid interfacial sequences in the context of the human BNIP3 non-
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interfacial sequence. Conceptually, this combines the HsBNIP3 dimerization 
motif, SHxxAlxxGlxxG, and the CeBNIP3 dimerization motif from TOXCAT, 
TNxxSFxxGAxxG, into a combined motif: (S/T)(H/N)xx(A/S)(l/F)xxG(l/A)xxG. 
Note that the non-interfacial residues (x) show almost no sequence conservation. 
To avoid having to randomize these positions, and because the NMR structure of 
the HsBNIP3 TMD dimer is available [121][Sulistijo and MacKenzie, submitted 
manuscript], I chose to build combinatorial libraries of interfacial residues in the 
context of the human BNIP3 TMD flanking sequences. Testing these sequences 
for homodimerization in detergents and in TOXCAT will allow me to determine 
whether the CeBNIP3 interfacial residues can support dimerization in the context 
of the HsBNIP3 flanking sequence, and how well non-native combinations of 
these interfacial residues support helix-helix interactions. 
4.1 All possible sequences formed by exchanging BNIP3 TMD interface motif 
residues demonstrate strong homodimerization in TOXCAT. 
To examine the homodimerization properties of this set of hybrid 
interfaces in membrane, I created a series of TOXCAT clones combining the two 
sets of motif residues in the context of the human BNIP3 transmembrane domain 
flanking sequence. Each clone corresponds to the HsBNIP3 TOXCAT construct 
containing between zero and five mutations at positions determined by scanning 
mutagenesis to correspond to the interacting surface. These clones are being 
made in the context of the HsBNIP3 TMD due to the existence of a solution-state 
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NMR structure [121]. By examining the self-associative capabilities of these 
hybrid TMDs and modeling the mutations onto an existing structure, we may 
begin to understand the specificity of BNIP3 TMD interactions from a structural 
standpoint. 
I designed an oligonucleotide sequence coding for the sequence of the 
HsBNIP3 TMD and containing degenerate locations to encode for any mixture of 
HsBNIP3 and CeBNIP3 interface residues. Inserts were created via PCR and 
ligated in-frame into the TOXCAT vector, resulting in a ToxR-hybridTMD-MBP 
protein construct containing the following TMD library: 
VFLPSLLL(S/T)(H/N)LL(A/S)(I/F)GLG(I/A)YIGRRLK, where bolded residues 
represent the dimerization interface (figure 4.1). The GxxxG motif, which is 
important to the dimerization properties of both orthologs, is not varied due to its 
conservation between species. These plasmids were transformed into NT326 
cells and assayed as described in section 2.1. 
TOXCAT revealed that the resulting sequences are similar in their ability 
to form homodimers in a cell membrane (figure 4.1). The construct containing 
the five interfacial residues from CeBNIP3 gives the same TOXCAT signal as 
HsBNIP3, indicating that the entire interface can be grafted from one 
hydrophobic host to another with no change in the measured dimerization. 
Although most hybrid interfaces give dimerization signals that are slightly lower 
than wildtype HsBNIP3, all demonstrate higher reporter gene production than the 
glycophorin A positive control. Only two of the 32 sequences give weak enough 
TOXCAT signals to be classified as 'slightly disruptive' using the scale applied to 
A . Potential BNIP3 mixed TMDs: VFLPSLLL (S /T) (H/N) LL (A/S) (i/F) GLG(I /A) YIGRRLK 
Human BNIP3 motif: VFLPSLLL S H LL A I GLG I YIGRRLK 
C. elegans BNIP3 Motif: VFLPSLLL T N LL S F GLG A YIGRRLK 
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Fig 4.1 Hybrid BNIP3 TMD interaction motifs homodimerize strongly in 
TOXCAT 
All interaction motifs formed by combining elements of the CeBNIP3 and 
HsBNIP3 binding surfaces into the context of the HsBNIP3 TMD form tight 
homodimers when expressed in TOXCAT. A. Hybrid Human and C. elegans 
BNIP3 dimerization motifs were created in the context of the HsBNIP3 TMD 
non-interacting sequence (motif residues in bold). Though the GxxxG motif is 
conserved and therefore invariable, five other residues differ. The resulting 
library contains all 30 possible combinations of the two motifs in addition to the 
wild-type Ce and Hs motifs. B. TOXCAT results from all hybrid motifs demon-
strate no significant differences in dimerization as determined by CAT activity, 
suggesting that all mixed sequences form approximately the same structure on 
the interaction surface. Clones are arranged by the number of residues altered 
from the wild-type human motif sequence. Controls include Glycophorin A (GpA, 
a strongly-associating TMD), GpA-G83l (a disruptive mutant), and wildtype 
CeBNIP3. 
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the scanning mutagenesis of CeBNIP3 dimerization in TOXCAT (section 3.5), 
and none of the hybrid interfaces would be classified as 'mostly disruptive' or 
'disruptive' on that scale. 
This finding suggests that the interfacial residues are essentially 
interchangeable and that the flanking sequence plays no significant role in 
dimerization of CeBNIP3 TMD. If the two ortholog TMDs contained residues that 
were incompatible with one another (e.g. the bulky F of CeBNIP3 clashed with 
the H of HsBNIP3 but not the smaller N of CeBNIP3) or if a single ortholog TMD 
contained a pair of residues that had co-evolved to support the interaction (e.g. 
the N and S of CeBNIP3 form a hydrogen bond that the A of HsBNIP3 cannot 
support), then I would have expected that some of these combinations of 
interfacial residues would have given significantly lower dimerization signals. It is 
possible that the wildtype BNIP3 TMD sequence is effectively saturating the 
TOXCAT assay, and that mutations significantly decrease the stability of the 
dimer but give rise to modest changes in TOXCAT signal (see Section 3.5 for a 
discussion). If this is the case, then the few hybrid interfaces that show slightly 
decreased self-association may have experienced substantial changes in 
dimerization propensity. 
The hybrid that gives the lowest TOXCAT signal has interfacial residues 
THxxAlxxGlxxG and differs at only the first position from the wildtype HsBNIP3 
sequence; the other hybrids that differ from the parental sequence by only one 
amino acid dimerize essentially as wildtype. I conclude that the S>T exchange 
decreases dimerization by the HsBNIP3 interface most of all the single residue 
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exchanges. Interestingly, the hybrid that gives the strongest dimerization signal 
has the other motif residue at every variable position, SNxxSFxxGAxxG, and 
thus differs from the wildtype CeBNIP3 interfacial sequence by only one residue. 
This is the only hybrid that associates more strongly than wildtype, and all other 
single residue exchanges associate significantly more weakly than wildtype. I 
conclude that the T>S exchange increases dimerization by the CeBNIP3 
interface, and that no other single residue exchange enhances dimerization of 
this sequence. These sets of observations both point to the first position in the 
motif as being most influential of the interfacial positions/outside of the GxxxG 
motif. However, it should be noted that the observed differences in TOXCAT 
signals could be influenced by differences in ToxR-TMD-MBP fusion protein 
levels; western blots indicate that expression levels are similar, but differences of 
±25% would likely be below our detection limit and could give rise to the 
observed variation in TOXCAT signals. 
From the minimal variation seen in the dimerization signals for the library 
of hybrid BNIP3 interfaces, it is my conclusion that the residues comprising 
CeBNIP3 TMD and HsBNIP3 form a very similar conserved structure that drives 
homodimerization in a cell membrane. The reason that residues can be 
exchanged between these interfaces without affecting dimerization substantially 
is that the geometry of the HsBNIP3 dimer interface accommodates the 
CeBNIP3 interfacial residues without clashes. I obtained the coordinates of the 
NMR structure of the wildtype HsBNIP3 TMD dimer from Endah Sulistijo (PDB 
ID: 2ka2) and built in mutations to the wildtype CeBNIP3 TMD interface using the 
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program Pymol. Most substitutions could be accommodated in the structure 
using rotamers consistent with the helix backbone, suggesting that similar 
accommodations for sidechain differences could be made in the context of a cell 
membrane. This information greatly broadens our ability to seek other 
oligomerizing transmembrane domains, as we now have experimental evidence 
for a broad spectrum of BNIP3-like interfaces. The more general motif 
(S/T)(H/N)xx(A/S)(l/F)xxG(A/l)xxG is therefore an appropriate sequence to use to 
search for BNIP3-like dimerization motifs in genomes. 
4.2 Hybrid motif BNIP3 TMDs demonstrate variable abilities to form 
homodimers in SDS-PAGE 
As previously discussed, the observations of TMD self-association in a 
membrane-based assay are not necessarily reflected in detergent micelles (see 
section 3.10). Detergents remain an important analytical tool, however, as many 
investigative methods such as solution-state NMR and ultracentrifugation require 
soluble, purified protein in an isotropic state. As such, the ability to express and 
analyze mixed-motif BNIP3 proteins in a detergent environment is required if 
further structural and biochemical experimentation is to be performed. However, 
conditions must be identified in which observed protein-protein interactions mimic 
those occurring in a biological system. As SDS-PAGE is a very common system 
in which interactions are observed and analyzed, and the parental BNIP3 TMDs 
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behave reasonably well in this system, I wished to see how SDS detergent 
affects the ability of hybrid motif BNIP3 TMDs to self-associate. 
I used PCR to amplify the hybrid TMDs from the previously created 
TOXCAT plasmids and ligated these sequences into the SNase expression 
vector. The resulting DNA sequences are in-frame protein chimerae consisting 
of SNase fused to the transmembrane domain of interest. Proteins were 
expressed and processed as previously described in section 2.2, with the 
addition of a high-salt wash to remove some impurities. Washed samples were 
mixed with loading buffer and separated by SDS-PAGE. Protein bands were 
visualized by Western blotting with antibodies directed against SNase. 
Many of the SNase-BNIP3 hybrid motif constructs associate poorly if at all 
in SDS-PAGE (see Figure 4.2.1). Eighteen of the 32 constructs, including the 
complete CeBNIP3 interfacial motif, show essentially no dimer. Only four of the 
32 constructs exhibit wildtype-like levels of dimer: wildtype itself, two constructs 
from the HA1 class, and one construct from the HA2 class. Tabulating the 
sequences with the most dimeric at the top allows a few trends to be identified. 
All four of the constructs that dimerize as wildtype and all four of those that 
are only slightly disrupted have an isoleucine at the fifth Variable position 
(position 181 in HsBNIP3), indicating that this residue confers a strong bias in 
favor of dimerization. The significance of all eight of the most stable dimers 
containing an He at a given position can be estimated by determining the 
probability of this occurring by chance; using the hypergeometric distribution, this 
probability is P = 0.0024. 
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Figure 4.2.1 Hybrid BNIP3-motif TMDs demonstrate varied dimerization 
phenotypes in SDS-PAGE. 
Combinations of motif residues from CeBNIP3 and HsBNIP3 were created in the 
span of non-interacting residues from HsBNIP3 and examined in detergent 
micelles. Combinations are ordered by distance from wild-type human 
sequence - a change of one residue (HA1) to a change of four residues (HA4). 
C. elegans motif is equivalent to HA5.While the human motif (Hs) drives strong 
dimerization in detergents, the C. elegans motif fails to form more than trace 
amounts of homodimer. Hybrid motifs drive dimerization to varying degrees, 
though most fail to interact more than the human sequence. 
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The only other residues that are distributed in ways that approach 
statistical significance are alanine at the third variable position (176 in HsBNIP3) 
and phenylalanine at the fourth variable position (177 in HsBNIP3). Although 
these residues are enriched in the strongly associating sequences, this is not 
statistically significant for these small sample sizes. However, both of these 
residues are equally under-represented in the least dimeric sequences (5 out of 
16), and this borders on statistical relevance (P = 0.075). No other residues 
appear to be distributed across the binned SDS-PAGE phenotypes in statistically 
significant ways. 
From these observations, I conclude that isoleucine (instead of alanine) at 
the fifth variable position in our library favors dimerization of hybrid BNIP3 motifs 
in SDS-PAGE. It is also likely that phenylalanine at the fourth variable position 
and alanine at the third variable position support stronger dimerization than the 
alternate choices (isoleucine or serine, respectively). Only four clones contain all 
three of these favored residues, and all four of these clones show strong 
dimerization. The other four clones that exhibit strong dimerization, including the 
wildtype HsBNIP3 motif, have two of these three residues. 
In contrast to what is seen with the TOXCAT constructs, grafting the entire 
C. elegans BNIP3 interface into the human BNIP3 flanking sequence gives a 
sequence that supports essentially no dimerization, and the hybrid motifs show a 
wide range of dimerization propensities that is biased towards monomer. This 
may suggest that the motif responsible for dimerization of CeBNIP3 in SDS-
PAGE, which differs slightly from the residues that drive dimerization in TOXCAT, 
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has not been completely transferred to the HsBNIP3 construct. Mutations at 
position 198 of CeBNIP3 affect dimerization in SDS-PAGE (Chapter 3.3), and 
this position has not been randomized in this library. Although the residue at the 
corresponding position in the SNase construct is Thr, which supports 
dimerization when introduced in CeBNIP3, the residues that precede this position 
are hydrophobic in CeBNIP3 but polar in HsBNIP3. 
It is interesting to note that the hybrid motif that shows the weakest 
dimerization in TOXCAT, THxxAlxxGlxxG, is one of the few sequences to form 
significant dimers in SDS-PAGE analysis, though the dimermonomer ratio is 
approximately 1:1. 
While hybrid BNIP3 TMD motifs drive dimerization to varying extents in 
SDS-PAGE and dimenmonomer ratios can be observed, additional bands can 
also be seen in the detergent environment (see figure 4.2.2, panel B). A 
transmembrane domain inserted into a micelle is assumed to form a stable helix 
in the hydrophobic core, but mutations in the transmembrane domain may 
reduce the overall polarity of the TMD and make conditions favorable for a region 
on the interior of the transmembrane domain to partition to the polar surface of 
the micelle, unfolding the protein and altering migration through the acrylamide 
gel. The addition of glycerol to SDS-PAGE can have a kosmotropic effect, 
encouraging protein folding and partitioning of the TMD into the core of detergent 
micelles by increasing hydrophobicity, thus reducing the fraction of improperly 
folded protein and the resulting anomalous protein bands (Endah Sulistijo, 
unpublished data). 
Figure 4.2.2 Addition of glycerol to SDS-PAGE promotes proper folding of 
transmembrane domains. 
A. Transmembrane domain interactions in detergent rely upon proper folding of the 
TMD helix. Mutations to the TMD that decrease hydrophobicity can make partition-
ing to the micelle surface favorable and result in a kinking of the TMD (left), disrupt-
ing any potential lateral interactions. The addition of glycerol to the detergent 
environment has a kosmotropic effect, driving proper TMD folding (center) and 
permitting lateral interactions (right). B. Hybrid BNIP3 TMDs run in standard SDS-
PAGE demonstrate numerous intermediate bands. C. The addition of glycerol to 
the SDS gel and loading buffer promotes folding, resulting in the reduction or elimi-
nation of anomalous intermediate bands. Additionally, some hybrid TMDs demon-
strate increased propensity to homodimerize in a glycerol/SDS environment (lanes 
2, 5, 8,10, and 14) suggesting that partitioning to the micelle surface may interfere 
with self-association. 
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To promote proper folding of hybrid transmembrane domains, glycerol was 
added to SDS-PAGE gels and SDS loading buffer to a final concentration of 
13%. Samples were resolved as previously described and gels were analyzed 
by western blotting. Samples analyzed under these conditions demonstrated a 
near complete loss of bands corresponding to unfolded protein, instead migrating 
as predicted by molecular weight. The addition of glycerol to SDS-PAGE also 
increases the propensity of hybrid BNIP3 TMDs to homodimerize (figure 4.2.2), 
consistent with the expectation that the unfolded protein has a lower tendency to 
self-associate. 
4.3 BNIP3 TMD dimerization in detergent correlates with hydrophobicity 
The ability of a transmembrane domain to form dimers in SDS, or any 
detergent, may be related to the overall hydrophobicity of the membrane span. 
The ability of a stretch of synthetic peptide to form helices in SDS correlates with 
its hydrophobicity [167]. This is likely due to a coupling between partitioning and 
folding, as described by Wimley and White [168]. A strongly hydrophobic stretch 
of peptide will partition out of water into the apolar core of a micelle due to the 
hydrophobic effect, and within the micelle core, helical hydrogen bond formation 
will be favored because of the relative absence of competing water. 
Transmembrane domains that are minimally hydrophobic or that contain polar 
patches may fail to partition into the micelle core and instead associate with the 
micelle/water interface, where they will be unstructured. Indeed, the ability of the 
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amphipathic micelle/water interface to favorably accommodate peptides of mixed 
polarity explains the ability of SDS to denature soluble proteins, which contain a 
mixture of polar and apolar amino acids. 
Many different scales have been developed for quantifying the relative 
hydrophobicity of amino acids in peptides and determining the thermodynamic 
propensity for polypeptides to partition into membranes. A set of free energy 
values based on biophysical partitioning data for short model peptides has been 
proposed by White and Wimley [168]. A biological hydrophobicity scale based 
on integration or secretion of a series of model transmembrane domains by the 
translocon has a similar but quantitatively distinct ranking of individual amino 
acids [15]. In our laboratory, Endah Sulistijo identified a series of non-interfacial 
single-residue substitutions that abrogated dimerization of HsBNIP3 TMD in SDS 
detergent; for these mutations, the degree of disruption correlated with the loss of 
hydrophobicity [57]. This observation led to the idea that the polarity of the 
residues within the TMD can influence the propensity to homodimerize in SDS. I 
have examined my hybrid motif library SDS-PAGE dimerization data seeking 
correlation with three hydrophobicity scales frequently used to identify 
transmembrane domains from primary sequence: the interface and octanol 
scales of White and Wimley [168], and the biological scale of von Heijne and 
colleagues [15]. 
In 1999, White and Wimley investigated the thermodynamic costs of 
partitioning into a lipid bilayer [168]. White and Wimley measured the energy 
requirements of partitioning from water into the bilayer hydrocarbon core, 
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including the energy required for H-bonded peptide bonds, into octanol [168]. 
The authors also investigated the free energy requirements for unfolded 
polypeptide chain insertion from water into a phosphatidylcholine bilayer [168]. 
These experiments provided a value for insertion of individual residues into the 
environment of choice. Additionally, Hessa et al used a series of designed poly-
alanine chains targeted to the translocon of the endoplasmic reticulum to 
indirectly determine the energy requirements of insertion of specific amino acids 
into a biological membrane [15]. In this series of experiments, Hessa et al 
generated transmembrane sequences that included a pair of leucine residues 
evenly spaced around a variable central residue. Using the probability of 
membrane insertion compared to the probability of insertion of the designed 
sequence including a changed central residue, the authors were able to 
determent the apparent free energy (AGapp) of the central residue, yielding a 
"biological" scale of amino acid polarities [15]. 
I took the residue hydrophobicity values provided by each of the 
abovementioned scales and used them to calculate the overall hydrophobicity of 
each hybrid BNIP3 motif (Table 4.3), including the potentially-ionized histidine 
residue (yielding 32 hydrophobic values and 16 values including ionization). The 
dimerization propensity of the set of constructs was then least-squares fit to each 
of the hydrophobicity scores using Excel. 
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Int 
-5.77 
-6.59 
-5.76 
-6.58 
-6.63 
-6.34 
-6.33 
-6.37 
-5.52 
-6.11 
-5.08 
-6.10 
-6.62 
-5.03 
-5.85 
-5.89 
-5.29 
-5.81 
-5.33 
-5.04 
-5.56 
-5.28 
-5.80 
-5.51 
-6.15 
-5.86 
-6.38 
-5.32 
-5.55 
-5.90 
-6.14 
-5.07 
Oct 
-7.65 
-8.24 
-7.86 
-8.45 
-8.28 
-7.50 
-7.71 
-7.75 
-6.91 
-6.62 
-5.33 
-6.83 
-8.49 
-5.50 
-6.09 
-6.13 
-6.03 
-7.69 
-6.07 
-5.29 
-6.95 
-6.24 
-7.90 
-7.12 
-6.66 
-5.88 
-7.54 
-6.28 
-7.16 
-5.92 
-6.87 
-5.54 
Biol 
2.69 
2.97 
2.37 
2.65 
3.71 
2.96 
2.64 
3.38 
2.68 
3.67 
4.12 
3.35 
3.39 
3.06 
3.34 
4.08 
3.39 
3.43 
4.13 
3.38 
3.42 
3.07 
3.11 
2.36 
4.41 
3.66 
3.70 
3.81 
3.10 
4.40 
4.09 
3.80 
Dimer 
0 
0 
0 
0 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
TX 
102.2 
88.9 
53.0 
92.2 
80.2 
77.4 
73.6 
80.7 
78.5 
74.1 
91.0 
84.7 
91.9 
64.2 
77.0 
98.3 
89.7 
93.5 
80.6 
81.5 
84.6 
70.0 
77.3 
57.3 
86.6 
93.1 
86.1 
82.9 
87.0 
111.0 
65.9 
71.8 
Table 4.3 TMD polarity affects the ability of BNIP3 transmembrane domains 
to dimerize in SDS-PAGE. 
Polarity values were calculated for the BNIP3 mixed-motif transmembrane 
domains and compared to their ability to significantly dimerize in SDS detergent. 
A value of 0 represents wild-type or greater dimenmonomer ratio, 3 represents 
trace or no dimer. Clones are organized by their propensity to form homodimers 
in detergent. Biological (biol) values were calculated based on numbers from 
Hessa et al, Nature, 2005; Interfacial (Int) and Octanol (Oct) values based on 
data from White and Wimley, Annu Rev Biophys Biomol Struct, 1999. Chloram-
penicol acetyl-transferase activity of each clone as measured by TOXCAT (TX) is 
provided. 
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When plotted as a regression (Figure 4.3), the octanol polarity scale yields 
a higher R2 value (0.322) than either the interfacial (0.257) or biological (0.270) 
scales (figure 4.3). This indicates that the octanol-water scale of hydrophobicity 
can account for about 32% of the variance in the difference of phenotype, 
compared to 26% for interfacial and 27% for biological hydrophobicities. In our 
laboratory, Endah Sulistijo calculated the hydropobicity changes of two pools of 
HsBNIP3 mutants that caused varying degrees of dimer abrogation in SDS [57]. 
She found that the biological scale as described by Hessa et al [15] accounted 
for about 50% of the variance in dimerization abrogation caused by non-
interfacial mutations, whereas octanol calculations accounted for significantly 
less variance and interfacial hydrophobicity correlation was virtually nonexistent 
[57]. Values obtained from single-point mutations of the entire HsBNIP3 TMD 
therefore show a more significant correlation than my results on hybrid motifs 
and match the biological scale of hydrophobicity instead of the octanol scale. 
However, it is important to note that the results obtained from HsBNIP3 
mutations include only substitutions to non-interfacial residues, the biological 
purpose of which may be to increase hydrophobicity to facilitate insertion into the 
membrane. In contrast, the hybrid motifs affect only the interacting residues at 
the dimerization interface, and therefore different properties may be required to 
preserve function. My observations show that, similar to the effect of 
hydrophobicity changes on TMD dimerization observed by Sulistijo at non-
interfacial positions [57], changes in hydrophobicity at the dimer interface affects 
the ability of a TMD to oligomerize in detergents. However, the hydrophobicity of 
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Figure 4.3 BNIP3 TMD Dimerization in SDS-PAGE correlates to hydropho-
bicity as measured using an octanol hydrophobicity scale. 
Plotting the propensity of hybrid BNIP3 TMDs to homodimerize in SDS-PAGE (0 
represents a wild-type HsBNIP3 dimer:monomer ratio, 3 represents trace or no 
dimerization) reveals a correlation when hydrophobicity is calculated using the 
octanol scale identified by White and Wimley (Annu Rev Biophys Biomol Struct, 
1999). This scale was identified by measuring the energy requirements for 
partitioning from water into an octanol layer, including H-bonded peptide bonds. 
These correlations suggest the polarity of a TMD affects the ability of a trans-
membrane domain to properly partition into detergent micelles and drive 
dimerization. Plotting based on octanol hydrophobicity identifies a group of 
twelve clones with hydrophobicity values more negative than -7.5 that contains 
all clones demonstrating a signficant tendency to homodimerize in SDS, suggest-
ing a minimum hydrophobicity required for dimerization in SDS. 
the dimer interface appears to correlate to a different relative scale of 
hydrophobicity. The hydrophobicity of a transmembrane domain must be a 
significant consideration when examining protein-protein interactions in vitro. 
4.4 Hybrid BNIP3 transmembrane domains show varying abilities to form 
heterodimers with wildtype HsBNIP3 and wildtype CeBNIP3 TMD 
A central goal of investigating transmembrane domain interactions is to 
determine the extent to which these interactions exhibit specificity: can 
transmembrane domains discriminate between different sequences, and how 
similar must such sequences be before they can interact with one another? 
HsBNIP3 has been shown to several have interaction partners, including 
Adenovirus E1B 19kD protein [100] and Bcl-2 [8], though the mechanism of 
interaction is unclear. Mutations to the HsBNIP3 TMD that disrupt dimerization in 
detergent do not necessarily disrupt its apoptotic function [8], though TOXCAT 
studies in our lab have demonstrated that many mutations that abrogate 
dimerization in detergent fail to disrupt when assayed in a cell membrane 
[Charles Lawrie & Kevin MacKenzie, personal communication]. Whereas 
CeBNIP3 and HsBNIP3 form strong homodimers, when assayed together in 
SDS-PAGE, the transmembrane domains of HsBNIP3 and CeBNIP3 do not 
interact significantly with one another [refer to section of the thesis], suggesting 
each interaction is specific for its own interface. 
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The observation that CeBNIP3 TMD and HsBNIP3 TMD fail to 
heterodimerize in detergent brings forth the question of specificity - namely, at 
what point does a transmembrane domain become specific and/or recognizable 
to CeBNIP3 or HsBNIP3? In section 4.3,1 described the creation of mixed-motif 
dimerization propensities in SDS-PAGE. In addition to the ability to determine 
the ability of a TMD to drive homodimerization in a detergent, the Staphylococcus 
nuclease assay permits us to determine the ability of a TMD to heterodimerize 
with another TMD by adding the transmembrane domain peptide to samples of 
fusion protein. Interaction of the protein with the added peptide causes the 
emergence of a heterodimer band in SDS-PAGE (described in 2.2). 
I used expressed hybrid motif proteins and added peptide corresponding 
to either wildtype HsBNIP3 TMD or wildtype CeBNIP3 TMD. These samples 
were separated by SDS-PAGE (12% acrylamide, 13% glycerol) to determine the 
propensity to form homodimers and heterodimers with added peptides (see 
Figure 4.4.1). All TMDs in figure 4.4.1 form strong homodimers with the notable 
exception of the motif TNxxSFxxGAxxG, the wildtype C. elegans dimerization 
motif. Wildtype human BNIP3 peptide was added to the samples in lanes 2, 5, 8, 
11, and 14, whereas wildtype C. elegans BNIP3 peptide was added to lanes 3, 6, 
9, 12, and 15. 
Figure 4.4.1 shows that hybrid BNIP3 TMDs can heterodimerize with 
wildtype peptides. The human SN-BNIP3 protein (lanes 4-6) forms strong 
homodimers (lane 4) and strong heterodimers with HsBNIP3 peptide (lane 5, 
determined both by the emergence of a heterodimer band migrating slower than 
Motif 
Sequence SNXXAFXXGIXXG 
~ 2 3~ 
HsBNIP3 TMD 
peptide added 
CeBNIP3 TMD . .
 + 
peptide added 
Figure 4.4.1 Hybrid BNIP3 TMDs demonstrate varying propensities for 
heterdimerization with HsBNIP3 TMD and CeBNIP3 TMD 
HsBNIP3 TMD peptide or CeBNIP3 TMD peptide were added to samples con-
taining SN-fused hybrid library motifs and run in SDS-PAGE (13% glycerol). 
Heterodimerization is judged by the emergence of a protein:peptide heterodimer 
band and reduction of protein homodimer. Wildtype HsBNIP3 shows a strong 
propensity for dimerization with HsBNIP3 TMD peptide (lane 5) but not with 
CeBNIP3 TMD peptide (lane 6), while the opposite is true for the hybrid CeBNIP3 
motif (lanes 14 and 15, respectively). Other hybrid BNIP3 motifs demonstrate 
varying abilities to form homodimers with added peptide, indicating different 
specificities depending on motif residues. 
SHxxAIxxGIxxG THxxAFxxGIxxG SHxxAFxxGAxxG TNxxSFxxGAxxG 
~4 5 6~~7 8 9~ 10 11 12* 13 14 15 
+ - - + . . + . - + . 
+ - - + - - + - - + 
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the monomer and by the reduction in dimer band intensity), though it interacts 
very poorly with the CeBNIP3 peptide (lane 6). The C. elegans motif hybrid 
(lanes 13-15) forms very little homodimer (lane 13), and while there is no 
apparent heterodimerization with the human BNIP3 peptide (lane 14), it does 
form heterodimers with the CeBNIP3 peptide (lane 15; heterodimer band 
appears to migrate faster in the gel than monomer). Thus, though the hybrid 
CeBNIP3 TMD motif in the context of the human background fails to interact 
significantly with either itself or the human BNIP3 peptide, oligomerization with 
the CeBNIP3 TMD peptide suggests that the C .elegans motif supersedes the 
non-motif residues in regard to retention of its specificity for association with 
CeBNIP3 TMD and not for HsBNIP3 TMD. 
Interestingly, a single residue substitution permits the C. elegans motif 
hybrid to heterodimerize with the wildtype HsBNIP3 peptide. Substitution of 
Asn183 of the CeBNIP3 motif to histidine (THxxSFxxGAxxG) while retaining the 
rest of the CeBNIP3 motif creates an interface capable of interacting with the 
human peptide, suggesting that the His residue is critical to determining the 
identity of HsBNIP3 interacting partners. Additionally, all eight of the mixed 
BNIP3 motifs that form interactions with the HsBNIP3 peptide possess a His at 
position 172, implicating it as a defining characteristic of hybrid BNIP3 TMDs able 
to form lateral interactions with wildtype HsBNIP3 in detergents. Analysis of the 
solution structure of HsBNIP3 TMD shows that the His173 sidechain extends 
between monomers and comes into proximity with Ser172 to form an interhelical 
hydrogen bond, stabilizing the dimer, and interaction with hybrid BNIP3 motifs 
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suggests that the formation of this bond is crucial for TMD-mediated HsBNIP3 
interactions and may be a determining factor for lateral interaction with HsBNIP3. 
Modeling hybrid BNIP3 TMDs onto the solution structure of HsBNIP3 TMD 
suggests that an interhelical hydrogen bond can be maintained by His173 by 
those hybrid TMDs demonstrating an interaction with HsBNIP3 (figure 4.4.2) 
The CeBNIP3 TMD peptide demonstrates a decreased ability to form 
heterooligomers with hybrid BNIP3 TMDs when compared to the human 
ortholog. Of the hybrid BNIP3 interfaces, only five (including the wildtype 
CeBNIP3 motif) demonstrate the ability to heterooligomerize with wildtype 
CeBNIP3. Of these hybrid motifs, no clear pattern emerges regarding the amino 
acid requirements for heterooligomerization with CeBNIP3 TMD, though three of 
the hybrid TMDs capable of strongly associating with CeBNIP3 TMD peptide 
contain a Phe at position 176. The presence of Phe176 may contribute to 
CeBNIP3 TMD interaction specificity in the context of the entire CeBNIP3 TMD 
sequence, though further study is required to observe less ambiguous 
observations to confirm this result. 
Hybrid BNIP3 TMDs demonstrate varying abilities to form heterodimers 
with wildtype BNIP3 TMDs. The hybrid TMD carrying the residues 
SNxxAFxxGlxxG (Figure 4.4.1, lanes 1-3) interacts strongly with the CeBNIP3 
TMD peptide despite carrying only two of five variable residues native to the C. 
elegans sequence; furthermore, it shows no propensity to heterodimerize with 
HsBNIP3. In contrast, the sequence carrying the motif THxxAFxxGlxxG (lanes 
7-9) forms very strong heterodimers with HsBNIP3 TMD peptide but shows no 
Figure 4.4.2 Structural modeling of hybrid BNIP3 TMD interfaces supports 
the formation of stable homodimers 
Hybrid BNIP3 TMD interactions can be modeled using the solution structure of 
HsBNIP3 as a basis. A. The NMR solution structure of a HsBNIP3 TMD dimer 
as solved by Endah Sulistijo. Ser172 and His173 from adjacent monomers come 
into close enough proximity (2.21 A) to form an interhelical hydrogen bond, stabi-
lizing the interaction in both detergents and membranes. B. Mutation of Ser172 
to Thr (from the CeBNIP3 TMD interface) results in no backbone permissible Thr 
sidechain rotamer that can replicate the close proximity of the Ser sidechain, 
preventing the formation of a hydrogen bond with the adjacent His173. C. Muta-
tion of Ala176 to Ser (corresponding to the CeBNIP3 TMD interface) permits a 
His173 rotamer to come into very close proxmity (1.90A) with the sidechain of 
residue 176, recreating the condition for hydrogen bond formation. D. The 
CeBNIP3 TMD interface modeled onto the HsBNIP3 solution structure. An 
Asn182 sidechain rotamer can extend to within 2.54A of Ser186, permitting 
hydrogen bond formation. This might account for the conservation of serine in 
this position by species containing the ThrAsn polar residue pair described in 
section 2.5. 
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ability to interact with the CeBNIP3 TMD peptide. The hybrid motif 
SHxxAFxxGAxxG (lanes 10-12) appears able to interact with both peptides. 
These results seem to suggest that some hybrid BNIP3 TMDs retain elements of 
specificity that permit them to interact with HsBNIP3 and CeBNIP3 
transmembrane domains, though the extent varies. Additionally, HsBNIP3 and 
the hybrid CeBNIP3 TMD fail to interact with each other, suggesting that though 
the residues may make similar interacting structures, they remain distinct enough 
to form specific interactions when none of these variable motif residues are 
common. Just two hybrid TMDs demonstrate the ability to interact strongly with 
both CeBNIP3 and HsBNIP3 wildtype peptides: SHxxSFxxGAxxG and 
SHxxAFxxGAxxG. Both of these hybrid motifs possess a histidine at position 
173, suggesting the possibility of His173 forming an interhelical hydrogen bond 
with Ser186 from the CeBNIP3 TMD to substitute for the absence of a bonding 
partner at position 172. Structural evidence suggests such an interaction is 
possible, as rotamers can place the histidine and serine in close enough 
proximity for a hydrogen bond to form between the helices (figure 4.4.2). 
Results of similar peptide competition experiments for all 32 hybrid motif SNase 
fusion proteins are presented in Table 4.4. 
Peptide Added 
9 SH—AI—GI—G 
14 SH—AI—GA—G 
151 SH—AF—GI—G 
31 SH—SI—GI—G 
20 SN—AI—GI—G 
105 TH—AI—GI—G 
115 SH—AF—GA—G 
143 SH—SI—GA—G 
47 SH—SF—GI—G 
22 SN—AI—GA—G 
1 SN—AF—GI—G 
33 SN—SI—GI—G 
173 TH—AI—GA—G 
51 TH—AF—GI—G 
121 TH—SI—GI—G 
7 TN—AI—GI—G 
170 SH—SF—GA—G 
95 SN—AF—GA—G 
138 SN—SI—GA—G 
30 SN—SF—GI—G 
205 TH—AH—GA—G 
204 TH—SI—GA—G 
5 TH—SF—GI—G 
98 TN—AI—GA—G 
123 TN—AF—GI—G 
36 TN—SI—GI—G 
202 SN—SF—GA—G 
104 TH—SF—GA—G 
195 TN—AF—GA—G 
118 T N — S I — G A — G 
201 TN—SF—GI—G 
203 TN—SF—GA—G 
Homodimer 
0 
3 
0 
3 
3 
1 
3 
3 
1 
3 
1 
3 
3 
0 
3 
3 
3 
3 
3 
3 
2 
3 
2 
3 
1 
3 
3 
2 
3 
3 
2 
2 
Hs 
0 
A1 
A1 
A2 
A3 
AO 
1 
A3 
A2 
A3 
3 
A3 
A3 
0 
A3 
A3 
A2 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
3 
Ce 
3 
A3 
A3 
A2 
A3 
A3 
A1 
A3 
A3 
A3 
0 
A3 
A3 
3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A3 
A2 
A3 
A1 
A2 
A2 
A3 
A3 
A3 
1 
Table 4.4 Hybrid BNIP3 TMDs demonstrate varying abilities to interact with 
wildtype HsBNIP3 and CeBNIP3 TMDs. 
Because of their tendency to migrate at the same rate in SDS-PAGE, protein 
monomers and protein:peptide heterodimers are difficult to differentiate, and 
observed results can be ambiguous. Results preceeded by "A" are ambiguous 
and heterodimerization propensity was estimated by the reduction in protein 
homodimer band intensity and increase in monomer/heterdimer band intensity 
when compared to samples lacking added peptide. 
0 Interacts strongly 
1 Interacts moderately 
2 Interacts weakly 
3 Does not interact 
Ambiguous Interactions scale, 
determined by reduction in 
homodimer band intensity 
when peptide is added 
A0 Interacts strongly 
A1 Interacts moderately 
A2 Interacts weakly 
A3 Does not interact 
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5. Conclusions, Implications, and Future Work 
Apoptosis has long been recognized as a critical process governing the 
development and continual maintenance of multi-cellular organisms, as indicated 
by its multiple pathways and myriad stimuli and regulatory participants. Since the 
recognition of programmed cell death the 1960s [169] and the creation of cell fate 
maps in C. elegans in the 1970s [122,125], apoptosis has blossomed into an 
intensive field of research due to its roles in many fundamental biological 
processes and its medical significance. Failure to properly regulate apoptotic 
function influences many medical conditions including cancers, HlV-related T-
lymphocyte death [170], viral infections [171], and many other disorders. The 
mitochondrion plays a significant role in controlling the apoptotic process [71]. 
Though release of cytochrome c is often a critical part of cell death and is 
regulated at least in part by members of the Bcl-2 protein family, a caspase-
independent pathway exists that includes regulation by the protein BNIP3 [120]. 
Since its identification as a component of cell death machinery [101], 
BNIP3 has been the target of extensive research, particularly in the field of 
oncology, where BNIP3 down-regulation has been implicated as a major 
characteristic of late-stage or aggressive tumor growth [110-118]. The exact 
mechanism of BNIP3 function in the cell is poorly understood, though the 
transmembrane domain is crucial to its apoptotic function [8, 89-91]. Additionally, 
BNIP3 is conserved throughout species, indicating that its role in apoptosis must 
have evolved early in multicellular eukaryotes. 
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Caenorhabditis elegans, long a mainstay of apoptotic and developmental 
research, possesses a BNIP3 ortholog originally identified in 1998 based upon a 
putative BH3 domain [103]. Despite low overall homology with its human 
orthologues, CeBNIP3 contains three major homology regions: its BH3 domain, a 
conserved region of 17 amino acids, and its transmembrane domain [12]. The 
ability of CeBNIP3 to drive apoptosis in mammalian cells [12] despite overall low 
homology makes it an interesting study in conservation of function over 
sequence. 
Assessing the basis of transmembrane domain dimerization in a cell 
membrane is crucial to understanding the biological relevance of any identified 
TMD-TMD interaction motif. Previous studies on transmembrane domain 
associations have demonstrated that polar residues in the context of a lipid 
bilayer can drive associations with other membrane proteins [57, 166, 172-175]. 
The underlying theory behind the propensity of polar sidechains contributing to 
lateral associations in membranes is derived from the idea that, due to their 
inability to extend polar sidechains into areas of thermodynamic favorability such 
as the polar head groups of membrane lipids, unsatisfied hydrogen bonding 
donors are more likely to form strong interactions with other free receptors in a 
similarly unfavorable environment and may even provide flexibility during 
interaction [175]. Asparagines, in particular, have been shown to drive homo-
and heterooligomerization in model transmembrane domains [172,176]. In 
addition to driving interactions between transmembrane domains, their stabilizing 
effects have been shown to be position-dependent, with a location near the 
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center of the transmembrane helix providing the most added stability [173]. One 
of the interesting conserved features of BNIP3 proteins is a pair of polar residues 
located near the center of the TMD. Mutational and structural analyses have 
demonstrated that the Ser-His polar residue pairing contributes to an interhelical 
hydrogen bond that, in addition to an AxxxGxxxG motif, further stabilizes self-
association [57, 121]. Similarly, BNIP3 protein TMDs from lower order organisms 
typically share a conserved Thr-Asn residue pairing that may perform a similar 
role in TMD self-association in a membrane, despite mutational analysis 
suggesting no role for these residues in homodimerization in a detergent micelle 
(see section 3.3). Because of these possibilities, substitutions were created 
along the entirety of the CeBNIP3 TMD to investigate the biological interface. 
This thesis has examined the conserved function of TMD-mediated 
homodimerization in both biological membranes and detergents for the first time, 
and has also investigated the conservation of structure-based interactions 
mediated by the BNIP3 transmembrane domain. The transmembrane domain of 
CeBNIP3 is sufficient to drive dimerization in both detergents and biological 
membranes (sections 3.1 and 3.4). I have identified two distinct interface motifs 
driving CeBNIP3 TMD-TMD interactions: S186xxxGxxxGxxxC/S is critical for 
dimerization in SDS (section 3.3) and N183xxxSFxxGxxxG is critical for 
dimerization in cell membranes (section 3.5). Since a common concern in 
biophysical and biochemical studies of membrane proteins is the relevance of 
detergents compared to biological conditions, I investigated the specificity of 
CeBNIP3 TMD-mediated interactions in both SDS detergent and in biological 
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membranes using the TOXCAT system. My mutagenesis experiments 
investigating the specificity of CeBNIP3 TMD interactions in SDS and in cell 
membranes reveals that the environment in which TMD interactions are 
investigated can alter the interaction specificity (section 3.6). I have also 
demonstrated that, though not affecting CeBNIP3 TMD dimerization at the 
concentrations I tested, that TOXCAT protein expression can be manipulated 
through mutational changes in the promoter and ribosome binding sites 
(Appendix 1), a useful tool for adjusting TOXCAT sensitivity to lateral TMD-TMD 
interactions. 
I have also demonstrated that, though the human BNIP3 and C. elegans 
BNIP3 transmembrane domains fail to interact with each other in detergents, 
their homodimerization is mediated by a structure similar enough that any 
combination of their interfacial residues also supports homodimerization in 
membranes (section 4.1). However, only a limited set of mixed-motif TMDs 
demonstrate the ability to form homodimers in detergent (section 4.2), further 
supporting the idea that a membrane-based assay is the preferable method for 
identifying TMD-TMD interactions. Previous studies have demonstrated that the 
hydrophobicity of flanking residues (those not participating at the interface) of a 
transmembrane domain can affect the behavior of proteins in SDS-PAGE [57], 
and I have now shown that a similar effect can be observed for even the amino 
acids forming a dimer interface (section 4.3). By competing wildtype HsBNIP3 
TMD peptide and wildtype CeBNIP3 TMD peptide against hybrid BNIP3 TMD 
domains, I have demonstrated that whereas CeBNIP3 TMD and HsBNIP3 TMD 
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do not interact, these sequences can interact with hybrid BNIP3 TMD motifs and 
two hybrid TMDs can even interact with both wildtype sequences (section 4.4). 
This suggests that BNIP3 TMDs form very similar structures but maintain enough 
specificity to prevent interacting with the entirety of the alternative motif. This 
may make TMD-TMD interactions more selective, as varying dimerization 
propensities might regulate heteromeric interactions in a biological system. 
One biological implication of identifying the specificity of the CeBNIP3 
transmembrane domain is that it may aid in the understanding of apoptotic 
pathways and the interactions of Bcl-2-mediated cell death. BNIP3 proteins have 
been identified as a participant in a cell death pathway more closely resembling 
necrosis than apoptosis [120], perhaps suggesting an apoptotic pathway in 
response to traumatic signals and requiring an expedited death. CeBNIP3 has 
several identified interaction partners in C. elegans [12], and though the role of 
this protein has been investigated in cells, the exact mechanism of this pathway 
remains a mystery. The C. elegans cell death pathway is reasonably well 
understood from a genetic perspective and can be manipulated using well-
established genetic tools varying from gene knockouts to RNAi manipulations, 
providing a useful model for investigating the role of TMD homodimerization in 
the development and homeostasis of a living organism. These tools can permit 
investigation of any specific developmental abnormalities stemming from 
expressed CeBNIP3 proteins carrying mutations at the transmembrane domain 
and can provide insight into the biological role of lateral TMD-TMD interactions. 
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Such experiments could shed light on the necessity of the functional 
conservation of the homodimerization of BNIP3 transmembrane domains. 
TOXCAT can be a useful tool for examining the specificity of families of 
related transmembrane domain interaction motifs. Since the specificities of 
CeBNIP3 and HsBNIP3 have been largely investigated by mutational [57] and 
structural [121] means, a motif can be identified wherein it could be reasoned 
that a pair of polar residues, a small residue followed immediately by a large 
nonpolar, and a GxxxG motif on a putative helical face will likely comprise an 
interaction motif that analysis in vitro might not identify due to reasons of low 
hydrophobicity. The investigation of the mixed-motif library sequences also 
provides information for predictions of function in a cell membrane. As all 
possible combinations of the two interaction motifs homodimerize with similar 
strengths in membranes, the number of sequences broadens in a search for 
similar interactions from 2 to 32 potential sequences. Identification of multiple 
sequences forming a similar structure could further expand the search criteria, 
providing far more potential interactions than could be previously identified. 
Furthermore, because the structure is similar enough to drive dimerization, 
heteromeric interactions should also be taken into account and, as a result, new 
interaction partners may be identified. I have shown that hybrid motif TMDs 
support heteromeric interactions with varying degrees of stability and specificity 
that are not fully explained at present. 
The hydrophobicity of a transmembrane domain also plays a role in 
oligomerization in SDS (section 4.3) and my findings in this area have 
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ramifications for the investigation of protein-protein interactions in detergents. 
The environment in which a protein is placed during the performance of 
biochemical, thermodynamic, and structural studies will affect the nature of its 
interactions and could provide misleading results based on environmental 
artifacts. The addition of this work to previously described effect of 
hydrophobicity on the dimerization of HsBNIP3 TMD [57] will aid in identifying 
detergent conditions that might provide more stable and biologically relevant 
interactions of transmembrane domains. This may assist in the determination of 
more transmembrane domain structures, which are greatly underrepresented in 
the protein structure databases because of the difficulty in handling these 
systems biochemically without disrupting their native structures. 
The future holds many possibilities for further research on the 
transmembrane domain of CeBNIP3. Though I have created a large quantity of 
single residue substitutions in two analytical systems, I have only created about 
one-third of all such possible mutants. Saturation mutagenesis of HsBNIP3 
revealed interesting mutations tolerated by HsBNIP3 TMD homodimers [57] that 
likely would not have been predicted by structural analysis alone and may assist 
in future predictions of interaction partners. Such complete mutagenesis data 
would provide a useful tool to complement the data presented in this thesis. This 
supplementary data could help in expanding the available search criteria for 
protein-protein interactions and the identification of new interaction partners in an 
expanding world of sequenced genomes. This could feasibly begin to uncover 
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new discoveries in the field of apoptosis research and have implications for future 
treatment of cancer or pf ischemia related to heart attacks or stroke. 
The role of C. elegans as a model organism, particularly in apoptotic 
studies, provides many opportunities for further investigation of TMD specificity in 
vivo. The mutations I created that abrogate CeBNIP3 TMD dimerization to 
varying degrees (section 3.5) could be expressed in C. elegans at various stages 
in development and in different cell lineages to visualize their effects, if any, on 
organism development. In addition to silencing or knockdown of endogenous 
CeBNIPS, BNIP3-driven apoptosis would be entirely regulated by the mutant 
protein, providing critical insight regarding the biological role of transmembrane 
domain-mediated self-association. The role of BNIP3 in development and 
homeostasis could be observed by loss of apoptotic function by certain lineages 
or failure to respond predictably to inducing stimuli such as hypoxia [104] or 
acidosis [105, 107]. 
Solution-state NMR structures of the HsBNIP3 transmembrane domain 
homodimer [121][Sulistijo, manuscript submitted], reveal a closely associated 
structure in which close packing interactions drive dimerization in conjunction 
with interhelical hydrogen bonding. Though I have demonstrated that the 
CeBNIP3 TMD and HsBNIP3 proteins likely share a conserved structure in spite 
of their sequence differences (section 4.1), structural studies would provide 
invaluable information on the specifics of CeBNIP3 TMD-TMD interactions. 
Expanding on this idea, the library sequences I created (section 4.2) could be 
competed with each other to determine which, if any, can heterooligomerize. 
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This would open a new avenue of structural and biological investigation - a 
heterooligomer structure would yield tremendous insight into the ability of 
proteins to conserve a function despite sequence drift and could enhance our 
ability to identify interacting partners and predict the mechanics of binding in a 
cell membrane. The addition of structure prediction to the arsenal of 
transmembrane domain mutagenesis and binding data could prove invaluable to 
the study of transmembrane protein structure and function. 
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A1.1 TOXCAT fusion protein construct concentration can be altered by 
mutations in the promoter region 
Russ and Engelman demonstrated that the association of TMDs in the 
TOXCAT assay is concentration-dependent [33]. By putting the ToxR-TMD-MBP 
fusion construct under the control of the inducible lac promoter, Russ and 
Engelman were able to manipulate the expression levels of the fusion protein in 
direct response to the addition of isopropyl p-D-thiogalactoside (IPTG) [33]. 
Predictably, self-association by TOXCAT constructs could be increased or 
decreased in a manner directly relative to protein expression [33]. Problems in 
determining the abrogative effect of a mutation could arise due to the possibility 
of a CAT expression limit in TOXCAT. This could be achieved if the amount of 
total protein dimer exceeds the available plasmid in a cell. Free protein dimers 
would be limited in the number of ctx transcriptional activation sites available for 
binding, causing an upper limit to protein expression. In this case, though 
mutations may reduce the dimenmonomer ratio in a membrane, the overall 
number of dimers could still exceed available plasmids and result in no significant 
reduction of TOXCAT signal. A potential solution to such a scenario would be to 
reduce the quantity of TOXCAT proteins in the membrane and thus reduce the 
number of protein dimers. 
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My early investigations in TOXCAT revealed that HsBNIP3 TMD dimers 
are somewhat less sensitive to abrogation due to mutation in a cell membrane 
than in SDS-PAGE. I used a binning scale to bin my TOXCAT results into four 
distinct phenotypes: not disruptive (55%-100% wildtype phenotype), slightly 
disruptive (38%-55% wildtype phenotype), mostly disruptive (17%-38% wildtype 
phenotype), and disruptive (0%-17% wildtype phenotype). Mutations that 
completely disrupted dimerization in vitro often exhibited TOXCAT signal 
approaching 50% wildtype (see figure 2.4) and would be thus classified merely 
as slightly disruptive. During my investigation of CeBNIP3 TMD dimerization in 
TOXCAT, it became clear that some mutations resulted in negligible changes to 
the strength of homodimerization despite coinciding with residues shown to be 
significant for HsBNIP3 TMD self-association. Previous mutagenesis data in 
SDS-PAGE and in TOXCAT also demonstrated that mutations demonstrate a 
less abrogation of dimerization in TOXCAT than in detergent. Reduction of 
protein concentration could reveal the effects of less-disruptive mutations by 
increasing the resulting abrogative effects and subsequent reporter gene 
expression. 
Reduction in TOXCAT protein expression could be achieved in any 
number of ways, including mutations to the promoter to weaken polymerase 
binding and disruption of ribosome binding sites, both of which I describe in this 
section. The ability to reduce expression in TOXCAT becomes significant due to 
the possibility of revealing disruptions due to mutation that are mostly invisible in 
high protein concentrations. By lowering the protein concentration in the 
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membrane, mutations resulting in smaller decreases of free energy may cause a 
greater difference in the dimenmonomer ratio. To reduce the amount of 
TOXCAT protein expressed, I decided on two approaches. The first strategy was 
to disrupt the transcriptional process by creating mutations within the 5' promoter 
region on the TOXCAT expression vector. The second strategy was the 
disruption of the ribosome binding site, aimed at reducing the ability of ribosomes 
to bind mRNA for protein translation. 
Promoters were identified using the BProm tool available from Softberry 
(www.softberrv.com). The promoters identified depended upon the length of 5' 
sequence provided to the BProm program. Long sequence inputs yielded a 
Sigma70 promoter consisting of a -35 sequence (GTGCAA) approximately 200 
bases 5' from the start codon and yielding a numerical score of 24 and a -10 
sequence (ATGTAAATT) with a score of 55. The insertion of a shorter sequence 
identified two alternative promoter sites with -35 boxes situated approximately 75 
and 135 nucleotides from the translational start. 
Several nucleotide substitutions were created by PCR mutagenesis with 
the intention of disrupting the function of the -10 box of the first identified 
promoter by reducing its similarity to the sigma70 consensus sequence. 
Sigma70 consensus has been determined to closely resemble a specific 
sequence for both the -35 box, TTGACA, and the -10 box, TATAAT [177, 178]. 
Nucleotides demonstrated to be most critical to -10 promoter function were 
targeted for replacement with nucleotides rarely occurring in the respective 
positions to maximize potential disruption (Figure A1.1.1). These mutants failed 
A. 
ttgagactcaatggaattaccttgatgtgcaagtgagatatggacaaaaaatgtaaattc 
aaggtcaaaactcataaaaacactgttttttgatcgagattggattattctaagtctgca 
tttttatcaaagaagataaaaaaaccagtaaagtctgagtgttgggacagggagatactg 
ggacattagatgttcggattaggacacaactcaaaagagatttcgatgagtcatattggt 
B. 
120.0 
100.0 
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f 60.0 
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Figure A1.1.1 Identification of the TOXCAT protein start and mutations to 
the promoter region 
A. The nucleotide sequence of the TOXCAT plasmid showing two potential 
in-frame start codons (bold). Insertion fo the sequence in the Softberry BPROM 
promoter identification tool identified a potential -35 and -10 promoter approxi-
amtely 200 nucleotides upstream from the translational start (grey text). The 
ribosome binding site is underlined. B. Mutation of the two potential translational 
start codons to leucine reveals that the second (M2L) encodes the first methion-
ine of the TOXCAT fusion protein. Western blotting confirms the lack of protein 
expression (inset). C. Promoter mutations and their effects on protein expres-
sion. Mutation of highly-conserved nucleotides at the identified -10 promoter 
failed to reduce TOXCAT expression significantly, suggesting that the BPROM 
tool fails to recognize the correct promoter of the TOXCAT gene construct. 
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to disrupt the expression of the TOXCAT fusion protein to any significant extent 
and, in the case of one, functioned to increase expression by nearly one hundred 
percent. These results indicate that the promoter for TOXCAT fusion construct 
expression was not identified by the BProm tool. Interestingly, BProm identified 
binding sites of potential transcriptional effectors throughout the promoter region 
that were changed in some instances by the created mutations and could 
account for some of differences in observed expression. 
Another potential method of expression reduction is to target and reduce 
mRNA translation by disrupting the ability of the ribosome to bind RNA. This 
would have the effect of reducing the protein concentration in the membrane by 
decreasing translational rates. The reduction in protein could make the TOXCAT 
assay more sensitive to changes in dimerization energy by shifting its 
concentration closer to its dissociation constant. Some bacteria have been 
shown to regulate gene translation via the occlusion of ribosome binding sites 
(RBS), creating proteins that recognize specific sequences near the RBS where 
they compete for binding [179-183]. I chose a mutational method to disrupt 
ribosome binding on the TOXCAT plasmid. The RBS consensus sequence in E. 
coli has been shown to resemble the sequence AGGAGA with the third 
nucleotide (guanine) located at the -9 position (relative to the translational start) 
being the most critical to ribosome binding [184]. A sequence of the promoter 
region of the pccKAN plasmid along with genbank entries for ToxR reveals two 
potential start codons, however, separated by twelve amino acids and each with 
an appropriately-placed potential ribosome binding site (Figure A1.1.1). 
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I focused initial experiments on the disruption of two potential ribosome 
binding sites situated with their critical guanines at the -8 and -18 upstream 
positions. To maximize the potential translational attenuation, I mutated the 
critical guanine of each potential RBS to thymine which would be expected to 
significantly reduce translation [184]. TOXCAT analysis and western blotting of 
the mutants transformed into NT326 cells revealed that mutation to the -18 
guanine failed to significantly reduce protein expression, indicating it is 
uninvolved in ribosome binding. Mutating the -8 guanine resulted in a 60% 
reduction of protein expression (Figure A1.1.2). While such a decrease suggests 
the site may be involved in translation in some way, a change from guanine to 
thymine at this important location is expected to reduce protein expression to a 
greater extent. 
To determine the true start of the ToxR subunit and the TOXCAT fusion 
construct in general, I individually mutated each of the potential start codons from 
ATG to CTG (Met to Leu). If the first possible codon was the translational start, 
mutation to CTG should disrupt translation and result in no protein product 
whereas a resulting M13L mutation would likely have little noticeable effect on 
TOXCAT function (position 13 is uninvolved in the transcriptional role of ToxR). 
Alternatively, if the second start codon is indeed the translational start, a single-
nucleotide mutation in the 5' untranslated region would likely have little effect on 
expression levels while a mutation to the start codon will disrupt translation. As 
predicted and in agreement with the majority of GenBank entries, a mutation to 
the second AUG codon resulted in a 100% reduction in TOXCAT signal while 
A. 
gcctatttttataggttaatgtcatgataataatggtttcttaggggcgcgtttctttat 
A Y F Y R L M S - - - W F L R G A F L Y 
tagtggttgcagtctcgctcataatcgctccgtttacttctgttccaaacaattgatcca 
- W L Q S R S - S L R L L L F Q T I D P 
ttgagactcaatggaattaccttgatgtgcaagtgagatatggacaaaaaatgtaaattc 
L R L N G I T L M C K - D M D K K C K F 
aaggtcaaaactcataaaaacactgttttttgatcgagattggattattctaagtctgca 
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Figure A1.1.2 Ribosome binding sites (RBS) can be mutated to alter fusion 
protein expression levels in TOXCAT 
The 5' untranslated region of the TOXCAT fusion construct contains three poten-
tial ribosome binding sites and two potential start codons. A. The true start 
codon as determined by site-directed mutagenesis and TOXCAT assay is under-
lined. Potential ribosome binding sites are in bold and numbered. The ribosome 
binding site consensus sequence is AGGAGA; the second guanine is the most-
conserved and the most critical to ribosome binding. To identify the true ribo-
some binding site, the critical guanine nucleotide was mutated to a thymine and 
assayed via TOXCAT to determine the effect of the mutation on protein transla-
tion. B. RBS mutants were created by substituting the critical guanine with a 
thymine for maximum disruption. C. TOXCAT results confirmed that RBS3 with 
a guanine -9 nucleotides from the start codon is likely the true RBS, as the 
thymine mutation resulted in a decrease in TOXCAT signal in excess of 80%. 
Similar mutations to the other potential RBSs resulted in slight to no difference in 
TOXCAT signal. Interestingly, the combined RBS1 and RBS2 mutations (labeled 
RBS1.2) actually returned protein translation to wild-type levels, indicating that 
neither is a site for ribosome binding. 
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mutation to the first had no effect, indicating that the second codon represents 
the n-terminal methionine (Figure A1.1.2, Panel B). Western blotting against 
MBP confirmed that mutation of the second potential start codon to CTG resulted 
in no expression of protein, whereas the upstream mutation had no effect on 
protein levels. 
A potential ribosome binding site exists upstream from the start codon of 
the TOXCAT construct and shares five of six nucleotides with the RBS 
consensus sequence (AAGAGA.6, where bolded nucleotides represent 
agreement with consensus). To maximally disrupt translation of the TOXCAT 
fusion construct, I chose to mutate the critical guanine to a thymine and 
transform the resulting mutated sequences into NT326 cells for TOXCAT. 
Protein expression was greatly reduced in this clone, with TOXCAT signal 
reduced by 85% and protein expression (Figure A1.1.2) reduced similarly 
(visualized via western blotting). 
All strategies presented demonstrate the ability to alter TOXCAT protein 
expression by causing single-base mutations in the 5'-untranslated region and 
the promoter region, with mutations resulting in protein production ranging from 
15% to 200% of wild-type expression levels. This spectrum of expression levels 
can provide a broad range of TOXCAT protein concentrations useful for 
manipulating the starting position on a binding curve and increasing the 
abrogative effects of minor disruptive mutations to a strong transmembrane 
homodimer. 
To determine the effect of reduced protein expression on CeBNIP3 TMD 
and mutant self-association, I chose a specific mutation to the ribosome binding 
site that reduced TOXCAT signal to approximately 40% wildtype expression. I 
created this point mutation in TOXCAT plasmids carrying inserts of wildtype 
CeBNIP3 TMD and every phenylalanine substitution mutant. TOXCAT samples 
were acquired and assayed as described in section 2.1. The reduction in protein 
concentration failed to reveal any additional abrogation due to mutation of 
CeBNIP3 TMD, as all Phe mutants maintained their approximate TOXCAT 
signals relative to wildtype (Figure A1.1.3). Though discouraging, this may be 
because the reduction from this mutant still is not sufficient to increase sensitivity 
enough to see small effects on the free energy of association. If TOXCAT 
protein still form more dimers than available DNA binding sites even after this 
reduction in expression, a further protein reduction could make he assay 
sensitive enough to detect small amounts of abrogation. 
A1.2 Optimization of membrane insertion via truncation of the transmembrane 
domain 
One important consideration when analyzing transmembrane domain 
interactions in TOXCAT is the fraction of protein inserted into the membrane. 
The process of membrane insertion and orientation has been shown to rely at 
least in part upon overall hydrophobicity of the TMD and targeting sequences 
located elsewhere in the protein [1851. In their development of the TOXCAT 
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Figure A1.1.3 Reduced expression does not alter relative CeBNIP3 TMD 
mutant phenotypes in TOXCAT. 
A mutation in the promoter region of the TOXCAT fusion protein gene causes a 
reduction in protein expression by approximately 60% (values shown are percent 
of wild-type). Reduced protein concentration in the cell membrane may provide 
the TOXCAT assay a greater sensitivity to disruptive mutations due to a binding 
curve shift. However, though protein expression was reduced, mutations to 
phenylalanine failed to demonstrate any change in relative phenotype when 
compared to reduced-expression wild-type CeBNIP3 TMD, suggesting protein 
concentrations remain too high to see small variations in dimerization energy. 
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assay, Russ and Engelman used a modified version of a spheroplast assay 
described by Chen and Kendall to determine the fraction of TOXCAT protein that 
successfully integrated into the lipid bilayer [33, 185]. By stripping away the cell 
wall and outer membrane from TOXCAT-expressing cells, the periplasmic 
maltose binding protein subunit can be exposed to solution [33]. Proteinase K is 
added to these spheroplasts resulting in the degradation of any exposed MBP, 
whereas cytosolic proteins including any soluble TOXCAT fusion protein are 
protected from digestion [33]. Spheroplasts are then washed and lysed and cell 
lysates are immunoblotted for maltose binding protein content [33]. The fraction 
of maltose binding protein preserved following proteinase K treatment relative to 
that of wild-type untreated cells indicates the relative amount of cytosolic fusion 
construct [33]. 
During his work on syndecan proteins in our lab, Ian Dews discovered that 
the TMD of Syndecan-2 formed inclusion bodies when expressed in TOXCAT. 
Syndecan proteins contain 25-residue transmembrane domains that demonstrate 
conservation of certain important elements including a GxxxG dimerization motif 
critical to homo- and hetero-dimeric function [139]. However, cells expressing 
TOXCAT fusion proteins with the full-length syndecan-2 TMD failed to grow on 
M9 maltose plates, indicating that the Syn2 TOXCAT construct failed to properly 
insert into the cell membrane [communications with Ian Dews, Kevin MacKenzie]. 
Proteolysis of spheroplasts containing the Syn2 TOXCAT construct confirmed 
that the Syn2 construct was protected from proteinase K [communications with 
Ian Dews, Kevin MacKenzie]. To resolve this problem, truncation mutants were 
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created which removed 2 or 4 residues from either side of the Syn2 TMD (see 
Figure A1.2.1) [communications with Ian Dews, Kevin MacKenzie]. Removing 
four residues from the C-terminal end (CA4) resulted in a clone that inserted 
properly and exhibited strong reporter gene expression [Ian Dews, data pending 
publication]. 
Mutational analysis of CeBNIP3 in TOXCAT generally fail to reduce the 
overall CAT levels more than 90% (excepting mutations to Gly190, discussed in 
section 3.5), suggesting some amount of background activity possibly due to 
improper insertion. CeBNIP3 TMD is 24 residues in length, one less than the 25 
residues constituting Syn2 TMD, and possibly of too great a length to function 
properly in TOXCAT. To investigate this possibility, I created truncation mutants 
of wildtype and mutant CeBNIP3 TMD that removed two or four residues from 
the n-terminus (NA2 and NA4) and analyzed the resulting clones in TOXCAT. 
Clones containing the NA2 deletion behaved similarly to wild-type CeBNIP3, with 
no significant reductions in baseline activity (see Figure A1.2.2). An exception 
was the Thr182Phe (NA2) mutant, which failed to insert properly based on malE 
complementation analysis. Of the NA4 truncation mutants created, the wild-type 
CeBNIP3 (NA4), Ala191Phe (NA4), and Gly194Phe (NA4) failed to properly insert 
into the membrane as demonstrated by failure to complement malE (see Figure 
A2.1.1) and mutations to interfacial residues failed to show any significant 
abrogation of dimerization (see Figure A1.2.3), consistent with the idea that the 
fusion proteins form inclusion bodies and constitutively express the TOXCAT 
fusion construct.. These data indicate that, unlike results observed with the 
A. 
wt: VVFGFLVTNIFSFVVGAAVGFAVS 
NA2: FGFLVTNIFSFVVGAAVGFAVS 
NA4: FLVTNIFSFVVGAAVGFAVS 
Fig A1.2.1 N-terminally truncated CeBNIP3 TMD fails to properly insert into 
the bacterial membrane. 
A. CeBNIP3 TMD was truncated by the removal of either two (NA2) or four 
(NA4) residues from the N-terminal end to reduce potential cytoplasmic inclusion 
bodies. Single-residue phenylalanine substitutions were created with these 
truncations to examine effects on the sensitivity of the TOXCAT assay to muta-
tion. B. Clones carrying the NA2 or NA4 mutations frequently failed to comple-
ment maltose, suggesting improper insertion or failure to insert. Most notably, 
wild-type CeBNIP3 TMD with the NA4 truncation (arrow) failed to properly insert. 
syndecan TMDs, truncations to the CeBNIP3 TMD do not improve its ability to 
insert and orient properly into the membrane. Accordingly, I have performed my 
mutational analyses using TOXCAT constructs carrying the full-length CeBNIP3 
TMD. 
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Figure A1.2.2 NA2 truncations of CeBNIP3 TMD display artificially high 
expression in TOXCAT 
Removal of two residues from the n-terminus of CeBNIP3 TMD disrupts 
CeBNIP3 insertion in the cell membrane and causes increased TOXCAT expres-
sion. Failure to insert into the membrane (confirmed by the inability to comple-
ment maltose) leads to the formation of inclusion bodies and constitutive 
TOXCAT expression in many cases. In the example of NA2 truncations, the 
mutation S186F demonstrates nearly wild-type TOXCAT expression, a dramatic 
increase in expression when compared to full-length CeBNIP3 TMD. 
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Figure A1.2.3 NA4 truncations of CeBNIP3 cause increases in TOXCAT 
signal due to improper membrane insertion. 
Similar to results observed with two-residue truncations, NA4 truncation mutants 
frequently fail to insert into the membrane as determined by maltose complemen-
tation. The resulting inclusion bodies drive TOXCAT expression constitutively, 
causing artifically high levels of TOXCAT protein expression. Due to failed inser-
tion, mutations known previously to disrupt dimerization in membranes often 
express at levels similar to wild-type. In the case of NA4 truncations, even wild-
type CeBNIP3 fails to complement maltose. 
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A2 Experimental Procedures 
Creation of ceBNIP3 TM domain mutants. Oligonucleotides are created for 
PCR mutagenesis with a degenerate codon designed to specifically mutate one 
residue to a set of alternative residues and potentially an extra mutation to 
disrupt an engineers restriction enzyme cut site. PCR is performed with 
oligonucleotides and either pec (TOXCAT) or XN2 (SN) expression vectors under 
normal conditions required for Pfu Turbo (Stratagene) activity. Reactions are 
transformed into XL-1 competent cells (Stratagene, La Jolla, CA) and 
miniprepped (Promega, Madison, Wl) to retrieve mutant DNA samples. Samples 
are digested to determine successful mutagenesis; mutants are sent for 
automated DNA sequencing (LoneStar Labs, Houston, TX). Desired mutants are 
transformed into NT326 (TOXCAT) [33] or BL21 (SNase) expression cells for use 
in assays. 15% glycerol stocks are created and stored at -80C until needed. 
SDS-PAGE assay for homodimerization 
Protein expression and SDS-PAGE sample creation. Desired mutants and 
controls (Glycophorin A, Glycophorin A (G83I), wt ceBNIP3) are inoculated from 
glycerol stocks into culture tubes containing 5mL Luria-Bertani (LB) broth 
supplemented with 50fxM/mL ampicillin. Cells are grown at 37C with shaking to 
OD42o =10 and induced with IPTG to 0.6mM. Protein is expressed for 3 hours 
at 37C with shaking. Cells are harvested and lysed by freezing three rounds of 
freezing and the addition of 0.1mg/mL chicken egg white lysozyme. 
Chromosomal DNA nucleation is carried by adding CaCb to a final concentration 
of 10mM with incubation on ice for 30 minutes. Cell extracts are centrifuged at 
maximum speed. The protein sample is associated with membrane debris in the 
pellet, and the supernatant is discarded. Pellets are resuspended in 100>L lysis 
buffer (20mM Tris-HCI, 2mM EDTA at a final pH of 8.0). Desired amounts of 
sample are then taken and added with volumes of 2*PSB and water to create 
SDS-PAGE samples. Samples are run in ReadyGels (BioRad, 15% acrylamide) 
for 70 minutes at 100V. 
Protein detection. Preliminary expression results are detected by immersing the 
gel in Coommassie Brilliant Blue R-250 for 1 hour, followed by destaining. 
Subsequent quantitative results are determined via western blot. Protein 
samples are transferred from SDS-PAGE gels to nitrocellulose membranes 
under conditions of 4C, 20mM Tris-HCI (pH 8.0), 0.5mM EDTA (pH 8.0), 20% 
isopropanol, 0.1% SDS (w/v). Membrane is blocked using milk. Membranes are 
exposed to anti-SNase primary antibody with secondary treatment of anti-rabbit 
IgG, horseradish peroxidase-linked antibody. Antibody is detected by exposure 
to detection reagents and observed with a FluorChem 5500 gel documentation 
station (Alpha Innotech). Bands are examined for relative expression levels and 
measured for homodimer (50kD) and monomer (24kD) ratios. 
TOXCAT assay for homodimerization 
Protein expression and TOXCAT sample creation. Desired mutants and controls 
(Glycophorin A, Glycophorin A (G83I), wt ceBNIP3) are inoculated from glycerol 
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stocks into culture tubes containing 5ml_ LB broth supplemented with 50|a.M/mL 
ampicillin. Cells are grown at 37C with shaking to OD420 = 1.0-1.2. Three OD420S 
of sample are pelleted by centrifugation and resuspended in lysis buffer (20mM 
Tris-HCI, 2mM EDTA (pH 8.0)) to remove traces of growth medium. Cells are 
pelleted by centrifugation and resuspended in 2mL lysis buffer, then lysed by 
sonication at 4C. 1mL cell whole cell lysate is removed and saved for western 
blotting. 1 ml_ is centrifuged to pellet cellular debris and the supernatant removed 
and saved for TOXCAT. 
CAT activity detection. TOXCAT samples are mixed in a 1:25 ratio with TOXCAT 
reaction buffer (100mM Tris-HCI (pH 8.0), 125nM Acetyl-CoA, 100^iM 5,5-dithio-
jb/s-(2-nitrobenzoic Acid)) and scanned for background absorption increase at 
412nm for three minutes. Chloramephenicol acetyl-transferase (CAT) is then 
added to a final concentration of 125fiM and mixed rapidly to obtain the initial 
slope of absorbance increase at 412nm. Both slopes are converted to units of 
CAT and background is subtracted from activity to yield relative CAT activity for 
each sample. All samples are run in triplicate. 
Maltose Complementation Assay. Remaining culture in LB growth medium are 
removed and pelleted by centrifugation. Pellets are resuspended in lysis buffer 
to dilute and remove remaining traces of growth medium, then pelleted again by 
centrifugation. Cells are resuspended in M9 minimal medium (maltose-only), 
plated on M9 minimal media (maltose-only), and grown at 37C until cellular 
growth can be observed. 
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Controls for expression levels by western blotting. Desired amounts of whole cell 
lysate are taken and added with volumes of 2*PSB and water to create SDS-
PAGE samples. Samples are run in ReadyGels (BioRad, 15% acrylamide) for 70 
minutes. Protein samples are transferred from SDS-PAGE gels to nitrocellulose 
membranes under conditions of 4C, 20mM Tris-HCI (pH 8.0), 0.5mM EDTA (pH 
8.0), 20% isopropanol, 0.1% SDS (w/v). Membranes are blocked using milk and 
exposed to anti-MBP primary antibody with secondary treatment of streptavidin 
horseradish peroxidase conjugate. Membranes are treated with detection 
reagent and signal observed with a FluorChem 5500 gel documentation system 
(Alpha Innotech). Bands are measured for relative expression levels. 
Expression and purification of ceBNIP3 TM domain peptide. 
Protein expression. Samples are inoculated into 5mL culture tubes containing M9 
minimal media (ammonium chloride as the single nitrogen source) supplemented 
with 50|aM carbenicillin and grown for twelve hours at 37C with shaking. 5mL is 
inoculated into 1L M9 minimal media and incubated with shaking at 37C to 
OD42o=1 -5 with 0.6mM IPTG. Expression continues at 37C for three hours. Cells 
are pelleted by centrifugation at 37C at 8000*g for30 minutes. Pellets are 
resuspended in 1/25 culture volume lysis buffer (20mM Tris-HCI, 2mM EDTA) 
and lysed by three rounds of freeze/thaw plus probe sonication. Samples are 
treated with hen egg white lysozyme and chromosomal DNA nucleation is carried 
out by the addition of 10mM CaCI2 and incubation on ice for 30 minutes. 
Protein purification. Whole cell lysate samples are first washed in conditions of 
low salt (20mM Tris-HCI, 0.5mM EDTA) and pelleted by centrifugation at 
12000xg for 30 minutes at 4C. SN-ceBNIP3 TMD remains associated with the 
pelleted debris. The pellet is resuspended and subsequently washed in 
conditions of high salt (1M ammonium acetate) and low salt with the addition of 
2% thesit detergent, during both of which SN-ceBNIP3 TMD remains insoluble. 
Protein extraction is performed under lysis buffer conditions with the inclusion of 
1M ammonium acetate and 2% thesit. Extracted samples are dialyzed twice 
against 20 volumes lysis buffer with 160mM ammonium acetate and 1% thesit. 
Insoluble fractions are removed by centrifugation at 12000*g at 4C. 
Samples are run through an anion-exchange column containing DE52 
resin under conditions of 160mM ammonium acetate, 2% thesit, and lysis buffer 
condition, from which SN-ceBNIP3 TMD protein collects in the flowthrough. 
Flowthrough fractions are then applied to a cation exchange SP column in an 
AKTAPrime system (Amersham). Thesit concentration is decreased to 0.1% and 
column volume is washed twice under these conditions. Ammonium acetate 
concentration is then increased steadily to 1M to release protein, which is 
removed from the column at approximately 650-750mM ammonium acetate. 
Sample fractions are then analyzed for total protein concentration by light 
spectroscopy at 276nm and those with significant protein content are combined. 
The remaining protein sample is digested with trypsin at a ratio of 1:25 
trypsin:protein for 8 hours at 37C. Digestion samples are removed and dialyzed 
against water for 8 hours at 4C with stirring. 
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Western blotting for peptide confirmation. Peptide samples are added to SNase-
linked CeBNIP3 TMD and diluted to concentration with 2x PSB. Samples are run 
in SDS-PAGE ReadyGels (BioRad, 15% acrylamide) at 100V. Protein samples 
are transferred from SDS-PAGE gels to nitrocellulose membranes under 
conditions of 4C, 20mM Tris-HCI (pH 8.0), 0.5mM EDTA (pH 8.0), 20% 
isopropanol, 0.1% SDS (w/v). Membrane is blocked using milk. Membranes are 
exposed to anti-SNase primary antibody with secondary treatment of anti-rabbit 
IgG, horseradish peroxidase-linked antibody. Antibody is detected by exposure 
to detection reagents and observed with a FluorChem 5500 gel documentation 
station (Alpha Innotech). Protein bands are analyzed for the emergence of a 
protein/peptide heterodimer band at approximately 31 kD. 
